residueId	AA	Amino acid residues	Amino acid properties	Secondary structure (PDBe/SIFTS)	Secondary structure (DSSP 3-state)*	Secondary structure (DSSP 9-state)*	Accessible surface area (Å²)*	Phi angle (degrees)*	Psi angle (degrees)*	AlphaFold confidence (pLDDT)	Active site (UniProt)	Binding site (UniProt)	Chain (UniProt)	Coiled coil (UniProt)	Compositional bias (UniProt)	Cross-link (UniProt)	Disulfide bond (UniProt)	DNA binding (UniProt)	Domain (UniProt)	Glycosylation (UniProt)	Initiator methionine (UniProt)	Intramembrane (UniProt)	Lipidation (UniProt)	Modified residue (UniProt)	Motif (UniProt)	Mutagenesis (UniProt)	Non-adjacent residues (UniProt)	Non-standard residue (UniProt)	Non-terminal residue (UniProt)	Peptide (UniProt)	Propeptide (UniProt)	Region (UniProt)	Repeat (UniProt)	Sequence conflict (UniProt)	Sequence uncertainty (UniProt)	Signal (UniProt)	Site (UniProt)	Topological domain (UniProt)	Transit peptide (UniProt)	Transmembrane (UniProt)	Zinc finger (UniProt)	Molar mass (g/mol)	Hydropathy	Acetylation	Disease-associated PTMs	Methylation	O-GalNAc	O-GlcNAc	Phosphorylation	SNP-associated PTMs	Regulatory sites	Substrate genes	SUMOylation	Ubiquitination	Pocket number (fpocket)*	Druggability score (fpocket)*	Intra-chain Hydrogen bond (PDB)	Intra-chain Hydrogen bond (AlphaFold2)	Intra-chain Non-bonded interaction (PDB)	Intra-chain Non-bonded interaction (AlphaFold2)	Intra-chain Disulfide bond (PDB)	Intra-chain Disulfide bond (AlphaFold2)	Intra-chain Salt bridge (PDB)	Intra-chain Salt bridge (AlphaFold2)	Inter-chain Hydrogen bond (PDB)	Inter-chain Non-bonded interaction (PDB)	Inter-chain Disulfide bond (PDB)	Inter-chain Salt bridge (PDB)	00001200-a-1 outliers⁺⁺	00001200-a-1 avg	00001200-b-1 outliers⁺⁺	00001200-b-1 avg	00001200-c-1 outliers⁺⁺	00001200-c-1 avg	00001200-d-1 outliers⁺⁺	00001200-d-1 avg	00001200-e-1 outliers⁺⁺	00001200-e-1 avg
1	M	Methionine	Aliphatic		C (loop/coil)	C (loop/coil)	240	360.0	122.5	37.79																										Signal						149	1.9																																			
2	Q	Glutamine	Polar/Neutral		C (loop/coil)	C (loop/coil)	191	-139.6	136.5	37.12																										Signal						146	-3.5																										1 mutation(s) (Gln2Ter: -0.062)	0.953		0.983	1 mutation(s) (Gln2Trp: 1.161)	0.965		0.965		0.962
3	R	Arginine	Positively-charged		C (loop/coil)	C (loop/coil)	241	52.1	135.6	34.0																										Signal						175	-4.5																											0.951		0.953		0.977		1.014		0.968
4	V	Valine	Aliphatic		C (loop/coil)	C (loop/coil)	122	102.5	96.7	37.48																										Signal						117	4.2																											0.985		1.002		1.007		1.002		0.999
5	N	Asparagine	Polar/Neutral		C (loop/coil)	C (loop/coil)	141	73.4	121.2	33.31																										Signal						132	-3.5																											0.961		0.986		0.989		0.989		0.976
6	M	Methionine	Aliphatic		C (loop/coil)	C (loop/coil)	172	161.8	106.7	38.7																										Signal						149	1.9																											1.012		0.979		0.979		0.983		0.986
7	I	Isoleucine	Aliphatic		C (loop/coil)	C (loop/coil)	132	76.1	123.8	38.98																										Signal						131	4.5																											0.984		1.013		0.998		1.002		0.999
8	M	Methionine	Aliphatic		C (loop/coil)	C (loop/coil)	179	77.3	116.8	40.18																										Signal						149	1.9																											1.038		1.018		1.032		1.027		1.032
9	A	Alanine	Aliphatic		C (loop/coil)	C (loop/coil)	98	-179.8	132.1	45.46																										Signal						89	1.8																											0.979		1.004		0.995		1.001		1.000
10	E	Glutamic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	196	-70.9	128.7	46.77																										Signal						146	-3.5																											0.990		1.006	1 mutation(s) (Glu10Lys: 1.142)	0.993		0.959		0.996
11	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	90	-108.2	115.7	53.56																										Signal						105	-0.8																											0.970		0.987		0.976		0.991		0.974
12	P	Proline	Special, No backbone hydrogen		C (loop/coil)	T (turn)	116	-73.2	12.3	54.66																										Signal						115	1.6																											1.031		1.024		1.024		1.014		1.025
13	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		H (helix)	H (α-helix)	37	-73.2	-15.5	55.01																										Signal						75	-0.4																	G13-I17; PAE: 5.0										0.924		0.944		0.960		0.973		0.953
14	L	Leucine	Aliphatic		H (helix)	H (α-helix)	127	-77.6	-28.0	57.05																										Signal						131	3.8															L14-C18; PAE: 4.0		L14-C18; PAE: 4.0										0.606		0.612		0.661		0.747		0.635
15	I	Isoleucine	Aliphatic		H (helix)	H (α-helix)	124	-79.3	-34.0	60.41																										Signal						131	4.5															I15-L19; PAE: 4.0		I15-L19; PAE: 4.0										0.610		0.637		0.678		0.804		0.645
16	T	Threonine	Polar/Neutral		H (helix)	H (α-helix)	89	-69.5	-32.9	61.07																										Signal						119	-0.7															T16-L20; PAE: 4.0		T16-L20; PAE: 4.0										0.862		0.887		0.907		0.938		0.892
17	I	Isoleucine	Aliphatic		H (helix)	H (α-helix)	120	-67.4	-39.3	63.0																										Signal						131	4.5															I17-G21; PAE: 4.5		I17-G13, I17-G21; PAE: 5.0, 4.5									1 mutation(s) (Ile17Gln: -0.024)	0.483		0.475		0.511		0.548		0.527
18	C	Cysteine	Special, a very reactive sulfhydryl group		H (helix)	H (α-helix)	75	-64.2	-40.3	61.08																										Signal						121	2.5															C18-L14, C18-Y22; PAE: 4.0, 3.5		C18-L14, C18-Y22; PAE: 4.0, 3.5										0.603		0.625		0.662		0.735		0.642
19	L	Leucine	Aliphatic		H (helix)	H (α-helix)	112	-69.6	-34.8	58.71																										Signal						131	3.8															L19-I15; PAE: 4.0		L19-I15, L19-L23; PAE: 4.0, 4.5										0.495		0.466		0.496		0.538		0.501
20	L	Leucine	Aliphatic		H (helix)	H (α-helix)	115	-66.7	-35.1	58.42																										Signal						131	3.8															L20-T16, L20-L24; PAE: 4.0, 4.5		L20-T16, L20-L24; PAE: 4.0, 4.5										0.459		0.422		0.471		0.503		0.476
21	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		H (helix)	H (α-helix)	41	-60.9	-41.2	58.91																										Signal						75	-0.4															G21-S25, G21-I17; PAE: 5.0, 4.5		G21-I17, G21-S25; PAE: 4.5, 5.0										0.840		0.873		0.888		0.930		0.864
22	Y	Tyrosine	Aromatic		H (helix)	H (α-helix)	186	-71.5	-31.6	59.15																										Signal						181	-1.3															Y22-C18; PAE: 3.5		Y22-C18; PAE: 3.5										0.745		0.726		0.759		0.811		0.744
23	L	Leucine	Aliphatic		H (helix)	H (α-helix)	141	-75.7	-29.9	58.02																										Signal						131	3.8																	L23-L19; PAE: 4.5										0.505		0.475		0.518		0.563		0.522
24	L	Leucine	Aliphatic		H (helix)	H (α-helix)	139	-81.5	-16.3	58.09																										Signal						131	3.8															L24-L20; PAE: 4.5		L24-L20; PAE: 4.5										0.595		0.631		0.692		0.768		0.648
25	S	Serine	Polar/Neutral		C (loop/coil)	T (turn)	82	-84.7	-0.7	56.0																										Signal						105	-0.8															S25-G21; PAE: 5.0		S25-G21; PAE: 5.0										0.892		0.938		0.952		0.978		0.936
26	A	Alanine	Aliphatic		C (loop/coil)	C (loop/coil)	67	-85.1	72.8	54.21																										Signal						89	1.8																										1 mutation(s) (Ala26Gln: 0.005)	0.504		0.509		0.585		0.613		0.541
27	E	Glutamic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	169	-67.1	85.8	59.64																										Signal						146	-3.5																											0.627		0.640		0.709		0.738		0.663
28	C	Cysteine	Special, a very reactive sulfhydryl group		C (loop/coil)	C (loop/coil)	112	-67.7	84.2	60.23																										Signal						121	2.5																										2 mutation(s) (Cys28Trp: -0.011, Cys28Leu: 0.006)	0.323		0.379		0.499		0.512		0.410
29	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	106	-66.4	112.4	67.18																					Propeptide											119	-0.7																											0.940		0.952		0.963	1 mutation(s) (Thr29Gly: 1.109)	0.964		0.958
30	V	Valine	Aliphatic		C (loop/coil)	S (bend)	133	-67.0	-24.2	76.29																					Propeptide											117	4.2																											1.109	2 mutation(s) (Val30Gln: 1.179, Val30Gly: 1.204)	1.080	1 mutation(s) (Val30Gly: 1.132)	1.052		1.005		1.101
31	F	Phenylalanine	Aromatic		C (loop/coil)	S (bend)	176	-100.1	137.5	75.54																					Propeptide											165	2.8																										4 mutation(s) (Phe31Pro: 1.366, Phe31Gly: 1.417, Phe31Ser: 1.419, Phe31Asn: 1.485)	1.184	6 mutation(s) (Phe31Val: 1.173, Phe31Ile: 1.191, Phe31Gln: 1.196, Phe31Ser: 1.216, Phe31Leu: 1.224, Phe31Asn: 1.274)	1.059	4 mutation(s) (Phe31Gln: 1.139, Phe31Asn: 1.143, Phe31Ile: 1.159, Phe31Gly: 1.171)	1.040		0.869	1 mutation(s) (Phe31Asn: 1.266)	1.055
32	L	Leucine	Aliphatic		H (helix)	P (polyproline helix)	100	-60.3	140.1	76.68																					Propeptide											131	3.8																										1 mutation(s) (Leu32Pro: 1.451)	1.103	2 mutation(s) (Leu32Tyr: 1.198, Leu32Ala: 1.246)	1.061	2 mutation(s) (Leu32Pro: 1.134, Leu32Ala: 1.139)	1.029		0.966		1.070
33	D	Aspartic Acid	Negatively-charged		H (helix)	P (polyproline helix)	79	-61.0	160.5	79.76																					Propeptide											132	-3.5															D33-A37; PAE: 2.0		D33-A37; PAE: 2.0										0.853		0.871		0.851		0.900		0.876
34	H	Histidine	Positively-charged		H (helix)	H (α-helix)	151	-55.0	-33.8	74.13																					Propeptide											155	-3.2															H34-N38; PAE: 2.5		H34-N38; PAE: 2.5										0.948		0.976		0.958		0.982		0.953
35	E	Glutamic Acid	Negatively-charged		H (helix)	H (α-helix)	142	-73.3	-39.6	74.59																					Propeptide											146	-3.5																	E35-K39; PAE: 3.5										0.954		0.957		0.944		0.966		0.936
36	N	Asparagine	Polar/Neutral		H (helix)	H (α-helix)	59	-75.3	-35.6	78.93																					Propeptide											132	-3.5																	N36-I40; PAE: 4.0										0.949		0.948		0.933		0.963		0.945
37	A	Alanine	Aliphatic		H (helix)	H (α-helix)	30	-61.5	-43.0	75.93																					Propeptide											89	1.8															A37-D33, A37-L41; PAE: 2.0, 4.0		A37-D33, A37-L41; PAE: 2.0, 4.0									5 mutation(s) (Ala37His: 1.359, Ala37Pro: 1.417, Ala37Tyr: 1.439, Ala37Asn: 1.470, Ala37Ile: 1.494)	1.151	1 mutation(s) (Ala37Thr: 1.173)	0.794		0.940		0.375	1 mutation(s) (Ala37Thr: 1.262)	0.578
38	N	Asparagine	Polar/Neutral		H (helix)	H (α-helix)	76	-67.1	-22.8	68.41																					Propeptide											132	-3.5															N38-H34; PAE: 2.5		N38-H34, N38-N42; PAE: 2.5, 5.5										1.034	3 mutation(s) (Asn38Asp: 1.176, Asn38Ser: 1.183, Asn38Glu: 1.183)	1.017		0.966		0.955		1.004
39	K	Lysine	Positively-charged		H (helix)	H (α-helix)	132	-72.1	-30.7	74.17																					Propeptide											147	-3.9																	K39-E35; PAE: 3.5									1 mutation(s) (Lys39Pro: 1.421)	1.010		0.974		0.928		0.876		0.972
40	I	Isoleucine	Aliphatic		H (helix)	H (α-helix)	122	-86.3	-49.6	74.4																					Propeptide											131	4.5																	I40-N36; PAE: 4.0									3 mutation(s) (Ile40Gly: 1.370, Ile40Ser: 1.408, Ile40Asn: 1.421)	1.120	2 mutation(s) (Ile40Pro: 1.178, Ile40Gly: 1.188)	0.979	2 mutation(s) (Ile40Asp: 1.143, Ile40Asn: 1.163)	1.028		0.663	1 mutation(s) (Ile40Gly: 1.260)	0.869
41	L	Leucine	Aliphatic		C (loop/coil)	S (bend)	124	-93.8	76.5	61.54																					Propeptide											131	3.8															L41-A37; PAE: 4.0		L41-A37; PAE: 4.0									5 mutation(s) (Leu41Gln: 1.336, Leu41Ala: 1.356, Leu41Pro: 1.373, Leu41Gly: 1.452, Leu41Asp: 1.465)	1.186	1 mutation(s) (Leu41Gln: 1.192)	1.009	1 mutation(s) (Leu41Ala: 1.160)	1.016		0.498	1 mutation(s) (Leu41Ala: 1.266)	1.082
42	N	Asparagine	Polar/Neutral		C (loop/coil)	C (loop/coil)	137	-66.7	84.9	57.45																					Propeptide											132	-3.5																	N42-N38; PAE: 5.5										0.948		0.950		0.926		0.878		0.934
43	R	Arginine	Positively-charged		C (loop/coil)	C (loop/coil)	169	-84.7	105.7	56.11																					Propeptide											175	-4.5																											1.024		1.006		0.978		0.039		1.039
44	P	Proline	Special, No backbone hydrogen		H (helix)	P (polyproline helix)	108	-52.8	138.7	58.38																					Propeptide											115	1.6																											0.932	1 mutation(s) (Pro44Thr: 1.192)	0.925	1 mutation(s) (Pro44Thr: 1.156)	0.926		0.953		0.926
45	K	Lysine	Positively-charged		H (helix)	P (polyproline helix)	210	-52.3	121.9	54.49																					Propeptide											147	-3.9																											0.959		0.926		0.924		0.192		0.973
46	R	Arginine	Positively-charged		H (helix)	P (polyproline helix)	95	-60.5	147.7	55.93																					Propeptide											175	-4.5															R46-E67, R46-E63; PAE: 6.5, 6.5												0.984		0.955		0.933	1 mutation(s) (Arg46Cys: -0.012)	0.092		0.951
47	Y	Tyrosine	Aromatic		C (loop/coil)	C (loop/coil)	188	-77.6	86.3	55.74		Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla																							181	-1.3														1 interaction		1 interaction											1.028		0.987	1 mutation(s) (Tyr47Ala: 1.152)	0.970		0.682		0.983
48	N	Asparagine	Polar/Neutral		C (loop/coil)	C (loop/coil)	83	-70.8	133.4	59.78		Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla																							132	-3.5																											1.003	1 mutation(s) (Asn48Asp: 1.217)	0.953		0.933		0.113		0.947
49	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	82	-62.0	-13.7	64.14			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							105	-0.8														1 interaction	S49-E66; PAE: 10.5	2 interactions										1 mutation(s) (Ser49Ter: -0.064)	0.988	1 mutation(s) (Ser49Asp: 1.186)	0.951	2 mutation(s) (Ser49Glu: 1.137, Ser49Asp: 1.154)	0.952		0.686		0.939
50	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	C (loop/coil)	S (bend)	42	150.4	-164.2	63.19			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							75	-0.4																											1.005	1 mutation(s) (Gly50Thr: 1.238)	0.981	2 mutation(s) (Gly50Asp: 1.136, Gly50Thr: 1.142)	0.977		0.545		1.015
51	K	Lysine	Positively-charged	Beta strand	C (loop/coil)	T (turn)	209	-62.6	130.0	62.02			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							147	-3.9																						2 interactions	1 interaction		1 interaction	1 mutation(s) (Lys51Gln: 1.519)	0.946		0.911		0.935		0.781	1 mutation(s) (Lys51His: 1.297)	0.880
52	L	Leucine	Aliphatic	Beta strand	C (loop/coil)	T (turn)	116	89.0	19.5	71.33			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							131	3.8																	L52-V56; PAE: 5.5										1.110	3 mutation(s) (Leu52Ser: 1.186, Leu52Asn: 1.186, Leu52Pro: 1.214)	1.065	6 mutation(s) (Leu52Gln: 1.136, Leu52Ser: 1.138, Leu52Thr: 1.153, Leu52Ile: 1.155, Leu52Glu: 1.161, Leu52Pro: 1.171)	1.050		0.747	2 mutation(s) (Leu52His: 1.273, Leu52Arg: 1.325)	1.077
53	E	Glutamic Acid	Negatively-charged		H (helix)	G (3₁₀-helix)	31	-52.2	-33.2	67.26		Ca(2+); Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5														1 interaction	E53-R62; PAE: 7.5	1 interaction											0.900		0.893		0.881	5 mutation(s) (Glu53Cys: -0.026, Glu53Trp: -0.013, Glu53Phe: -0.010, Glu53Gly: -0.008, Glu53Lys: -0.006)	0.052		0.853
54	E	Glutamic Acid	Negatively-charged		H (helix)	G (3₁₀-helix)	182	-56.1	-22.1	71.37		Ca(2+); Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5																1 interaction											0.915		0.892		0.873	2 mutation(s) (Glu54Cys: -0.015, Glu54Ile: -0.012)	0.064		0.956
55	F	Phenylalanine	Aromatic		H (helix)	G (3₁₀-helix)	164	-99.1	-5.4	77.48			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							165	2.8																						1 interaction				1 mutation(s) (Phe55Thr: 1.366)	1.111	3 mutation(s) (Phe55Asn: 1.186, Phe55Ser: 1.196, Phe55Thr: 1.218)	1.082	7 mutation(s) (Phe55Thr: 1.132, Phe55His: 1.136, Phe55Glu: 1.136, Phe55Pro: 1.140, Phe55Met: 1.141, Phe55Asn: 1.147, Phe55Gln: 1.149)	1.062		0.900		1.084
56	V	Valine	Aliphatic		C (loop/coil)	S (bend)	66	-89.4	128.6	72.9			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							117	4.2																	V56-L52; PAE: 5.5										0.944	1 mutation(s) (Val56Glu: 1.210)	0.935	3 mutation(s) (Val56Gly: 1.132, Val56Pro: 1.141, Val56Thr: 1.192)	0.933		0.400		0.931
57	Q	Glutamine	Polar/Neutral		H (helix)	P (polyproline helix)	175	-59.9	129.9	74.91			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							146	-3.5														1 interaction	Q57-R62; PAE: 4.5								2 interactions			1 mutation(s) (Gln57Asn: 1.384)	0.964		0.922	1 mutation(s) (Gln57Asp: 1.142)	0.925	3 mutation(s) (Gln57Cys: -0.019, Gln57Trp: -0.012, Gln57Arg: -0.009)	0.132		0.861
58	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		H (helix)	P (polyproline helix)	54	-55.2	124.9	70.69			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							75	-0.4																										1 mutation(s) (Gly58Pro: 1.515)	0.974	1 mutation(s) (Gly58Lys: 1.197)	0.928		0.945	1 mutation(s) (Gly58Ile: -0.007)	0.369		0.900
59	N	Asparagine	Polar/Neutral		C (loop/coil)	C (loop/coil)	60	-134.2	115.4	79.3			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							132	-3.5															N59-E63; PAE: 3.0		N59-E63; PAE: 3.0										0.879		0.886		0.894		0.368	1 mutation(s) (Asn59His: 1.274)	0.776
60	L	Leucine	Aliphatic	Helix	H (helix)	H (α-helix)	30	-63.0	-36.8	74.11			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							131	3.8														3 interactions	L60-C64; PAE: 1.5	5 interactions	L60-C64; PAE: 1.5									3 mutation(s) (Leu60Ser: 1.338, Leu60Gly: 1.389, Leu60Ala: 1.399)	1.230		0.984	1 mutation(s) (Leu60Pro: 1.133)	1.004		0.377	6 mutation(s) (Leu60Gly: 1.277, Leu60Gln: 1.279, Leu60Pro: 1.288, Leu60Asn: 1.297, Leu60Val: 1.298, Leu60His: 1.308)	1.085
61	E	Glutamic Acid	Negatively-charged	Helix	H (helix)	H (α-helix)	95	-59.9	-43.3	73.7		Ca(2+); Mg(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5												Pocket 5: Mean pLDDT: 74.14, Volume: 208.89 Å³, Druggability score: 0.02	0.0171		E61-M65; PAE: 1.5		E61-M65; PAE: 1.5									1 mutation(s) (Glu61Thr: 1.355)	1.037		0.915		0.890		0.356	10 mutation(s) (Glu61Met: 1.282, Glu61Pro: 1.299, Glu61Thr: 1.300, Glu61Arg: 1.305, Glu61Gly: 1.311, Glu61Tyr: 1.325, Glu61Asn: 1.332, Glu61Gln: 1.333, Glu61Ala: 1.334, Glu61His: 1.341)	1.165
62	R	Arginine	Positively-charged	Helix	H (helix)	H (α-helix)	60	-63.1	-52.9	80.75			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							175	-4.5														1 interaction	R62-E53, R62-Q57, R62-E66; PAE: 7.5, 4.5, 2.0		R62-E66; PAE: 2.0										1.015		0.940		0.951	1 mutation(s) (Arg62Asp: -0.010)	0.201		0.463
63	E	Glutamic Acid	Negatively-charged	Helix	H (helix)	H (α-helix)	40	-61.0	-43.9	79.55		Ca(2+); Ca(2+); Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5															E63-E67, E63-N59, E63-R46; PAE: 2.5, 3.0, 6.5		E63-E67, E63-N59; PAE: 2.5, 3.0																		
64	C	Cysteine	Special, a very reactive sulfhydryl group	Helix	H (helix)	H (α-helix)	1	-59.3	-43.3	80.95			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 64-69		Gla																							121	2.5														4 interactions	C64-K68, C64-L60; PAE: 3.0, 1.5	5 interactions	C64-K68, C64-C69, C64-L60; PAE: 3.0, 2.5, 1.5										0.886		0.950		1.000		1.042		1.084
65	M	Methionine	Aliphatic	Beta strand	H (helix)	H (α-helix)	132	-69.4	-36.4	74.0			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							149	1.9												Pocket 5: Mean pLDDT: 74.14, Volume: 208.89 Å³, Druggability score: 0.02	0.0171	1 interaction	M65-E61; PAE: 1.5	3 interactions	M65-E61; PAE: 1.5										1.013		0.944		0.956		0.738	5 mutation(s) (Met65Thr: 1.255, Met65Tyr: 1.297, Met65His: 1.323, Met65Gln: 1.327, Met65Lys: 1.327)	0.985
66	E	Glutamic Acid	Negatively-charged	Beta strand	H (helix)	H (α-helix)	47	-72.9	-38.7	77.74		Ca(2+); Mg(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5															E66-R62, E66-S49; PAE: 2.0, 10.5		E66-R62; PAE: 2.0										0.936		0.775		0.739		0.514		0.690
67	E	Glutamic Acid	Negatively-charged	Beta strand	H (helix)	H (α-helix)	39	-118.6	-6.6	76.29		Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5															E67-R46, E67-E63; PAE: 6.5, 2.5		E67-E63; PAE: 2.5										0.902		0.893		0.819	5 mutation(s) (Glu67Cys: -0.019, Glu67Trp: -0.013, Glu67Ile: -0.006, Glu67Val: -0.006, Glu67Phe: -0.006)	0.103		0.516
68	K	Lysine	Positively-charged		C (loop/coil)	C (loop/coil)	175	54.9	102.4	76.58			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							147	-3.9														1 interaction	K68-C64; PAE: 3.0	3 interactions	K68-C64; PAE: 3.0										1.069		0.943	4 mutation(s) (Lys68Asn: 1.141, Lys68Ala: 1.150, Lys68Glu: 1.162, Lys68Gln: 1.174)	0.987		0.687		0.878
69	C	Cysteine	Special, a very reactive sulfhydryl group		C (loop/coil)	C (loop/coil)	17	-91.9	160.9	83.86			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 64-69		Gla																							121	2.5														2 interactions	C69-Y91; PAE: 3.0	1 interaction	C69-C64; PAE: 2.5									1 mutation(s) (Cys69Ser: 1.371)	0.925		0.493		0.563	7 mutation(s) (Cys69Tyr: -0.017, Cys69Trp: -0.016, Cys69Asp: -0.012, Cys69Ile: -0.009, Cys69Glu: -0.007, Cys69Gln: -0.007, Cys69Gly: -0.003)	0.050		0.299
70	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	54	-86.4	161.1	85.86			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							105	-0.8														1 interaction	S70-A74; PAE: 1.0	2 interactions	S70-A74; PAE: 1.0										1.030		0.928		0.944		0.594	1 mutation(s) (Ser70His: 1.275)	0.949
71	F	Phenylalanine	Aromatic	Helix	H (helix)	H (α-helix)	72	-58.8	-38.7	85.84			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							165	2.8														3 interactions	F71-R75; PAE: 1.0	4 interactions	F71-R75; PAE: 1.0									1 mutation(s) (Phe71Asp: 1.428)	1.151		0.958	1 mutation(s) (Phe71Asp: 1.146)	0.971		0.469		1.036
72	E	Glutamic Acid	Negatively-charged	Helix	H (helix)	H (α-helix)	87	-65.2	-42.3	86.25		Ca(2+); Mg(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5															E72-E76; PAE: 1.0		E72-E76; PAE: 1.0									10 mutation(s) (Glu72Ala: 1.355, Glu72Leu: 1.368, Glu72Arg: 1.370, Glu72Lys: 1.370, Glu72Asp: 1.380, Glu72Phe: 1.381, Glu72His: 1.388, Glu72Trp: 1.405, Glu72Pro: 1.407, Glu72Val: 1.453)	1.284	1 mutation(s) (Glu72Asn: 1.171)	0.976	1 mutation(s) (Glu72Asp: 1.161)	0.950		0.631	12 mutation(s) (Glu72Phe: 1.286, Glu72Met: 1.289, Glu72Asn: 1.309, Glu72Asp: 1.313, Glu72His: 1.314, Glu72Ala: 1.316, Glu72Leu: 1.316, Glu72Val: 1.318, Glu72Arg: 1.320, Glu72Ile: 1.326, Glu72Pro: 1.327, Glu72Lys: 1.330)	1.203
73	E	Glutamic Acid	Negatively-charged	Helix	H (helix)	H (α-helix)	79	-62.5	-41.0	86.94		Ca(2+); Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5																	E73-V77; PAE: 1.5										1.004		0.808		0.840	5 mutation(s) (Glu73Lys: -0.019, Glu73Trp: -0.013, Glu73Ala: -0.005, Glu73Tyr: -0.005, Glu73Cys: -0.004)	0.061	4 mutation(s) (Glu73Thr: 1.256, Glu73Asn: 1.284, Glu73Gly: 1.293, Glu73Ser: 1.308)	0.964
74	A	Alanine	Aliphatic	Helix	H (helix)	H (α-helix)	0	-63.5	-40.0	85.8			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							89	1.8														4 interactions	A74-F78, A74-S70; PAE: 1.5, 1.0	4 interactions	A74-T84, A74-F78, A74-S70; PAE: 2.0, 1.5, 1.0																		
75	R	Arginine	Positively-charged	Helix	H (helix)	H (α-helix)	93	-64.7	-39.7	87.64			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							175	-4.5														3 interactions	R75-E79, R75-F71; PAE: 3.5, 1.0	6 interactions	R75-E79, R75-F71, R75-T84; PAE: 3.5, 1.0, 2.0									1 mutation(s) (Arg75Asp: 1.392)	1.061	1 mutation(s) (Arg75Asp: 1.186)	0.920	2 mutation(s) (Arg75Gly: 1.143, Arg75Asp: 1.171)	0.944	1 mutation(s) (Arg75Asp: 1.099)	0.830	5 mutation(s) (Arg75Lys: 1.270, Arg75Asn: 1.277, Arg75His: 1.287, Arg75Asp: 1.310, Arg75Gly: 1.315)	1.053
76	E	Glutamic Acid	Negatively-charged		H (helix)	H (α-helix)	125	-62.6	-32.7	86.14		Ca(2+); Ca(2+); Mg(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5															E76-E72; PAE: 1.0		E76-E72; PAE: 1.0									7 mutation(s) (Glu76His: 1.343, Glu76Thr: 1.375, Glu76Phe: 1.413, Glu76Met: 1.415, Glu76Cys: 1.417, Glu76Pro: 1.430, Glu76Asn: 1.436)	1.248	2 mutation(s) (Glu76His: 1.180, Glu76Lys: 1.192)	0.977		0.976	1 mutation(s) (Glu76Phe: -0.005)	0.105	10 mutation(s) (Glu76Phe: 1.258, Glu76Ser: 1.267, Glu76Ile: 1.268, Glu76Arg: 1.287, Glu76Thr: 1.290, Glu76Val: 1.292, Glu76Gly: 1.293, Glu76His: 1.297, Glu76Pro: 1.307, Glu76Asn: 1.315)	1.153
77	V	Valine	Aliphatic		H (helix)	H (α-helix)	83	-86.3	-43.0	82.16			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							117	4.2																	V77-E73; PAE: 1.5									2 mutation(s) (Val77Gly: 1.338, Val77Pro: 1.430)	1.102	1 mutation(s) (Val77Pro: 1.200)	1.004	1 mutation(s) (Val77Asn: 1.140)	0.989		0.534	2 mutation(s) (Val77Gly: 1.264, Val77Pro: 1.294)	0.992
78	F	Phenylalanine	Aromatic	Beta strand	H (helix)	H (α-helix)	44	-74.2	-21.9	85.25			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							165	2.8														3 interactions	F78-A74; PAE: 1.5	4 interactions	F78-T84, F78-A74; PAE: 2.5, 1.5									6 mutation(s) (Phe78Asn: 1.349, Phe78Gln: 1.374, Phe78Ser: 1.397, Phe78Gly: 1.439, Phe78Arg: 1.459, Phe78Glu: 1.468)	1.149	5 mutation(s) (Phe78Glu: 1.170, Phe78Asn: 1.177, Phe78Pro: 1.188, Phe78Arg: 1.206, Phe78Gln: 1.218)	0.994	4 mutation(s) (Phe78Gly: 1.146, Phe78Arg: 1.153, Phe78Glu: 1.174, Phe78Pro: 1.224)	0.976		0.429	2 mutation(s) (Phe78Glu: 1.262, Phe78Pro: 1.306)	1.036
79	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	C (loop/coil)	176	49.6	22.1	86.43			Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5															E79-R75; PAE: 3.5		E79-R75; PAE: 3.5										1.049	2 mutation(s) (Glu79Gln: 1.209, Glu79Lys: 1.253)	1.010	1 mutation(s) (Glu79Thr: 1.137)	0.965	1 mutation(s) (Glu79Gln: 1.103)	0.759	2 mutation(s) (Glu79Asn: 1.294, Glu79Pro: 1.295)	0.990
80	N	Asparagine	Polar/Neutral	Beta strand	C (loop/coil)	C (loop/coil)	63	-151.6	115.0	89.38			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							132	-3.5														2 interactions	N80-T84; PAE: 2.0	3 interactions	N80-T84; PAE: 2.0										0.970	1 mutation(s) (Asn80Asp: 1.173)	0.798		0.834		0.543	1 mutation(s) (Asn80Pro: 1.280)	0.855
81	T	Threonine	Polar/Neutral	Helix	H (helix)	H (α-helix)	93	-59.7	-37.0	87.73			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							119	-0.7														2 interactions	T81-T85; PAE: 1.0	4 interactions	T81-T85; PAE: 1.0										0.993		0.971		0.943		0.967		0.899
82	E	Glutamic Acid	Negatively-charged	Helix	H (helix)	H (α-helix)	151	-65.9	-49.9	88.4		Ca(2+); Mg(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5															E82-E86; PAE: 1.0		E82-E86; PAE: 1.0									2 mutation(s) (Glu82Asp: 1.353, Glu82Asn: 1.405)	1.113		0.879		0.857		0.674		0.885
83	R	Arginine	Positively-charged	Helix	H (helix)	H (α-helix)	158	-62.1	-42.2	87.18			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							175	-4.5														2 interactions	R83-F87; PAE: 1.0	3 interactions	R83-F87; PAE: 1.0										1.034		0.982	1 mutation(s) (Arg83Asn: 1.134)	0.961		0.907	1 mutation(s) (Arg83Asn: 1.264)	1.026
84	T	Threonine	Polar/Neutral	Helix	H (helix)	H (α-helix)	0	-59.5	-41.8	87.4			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							119	-0.7														4 interactions	T84-W88, T84-N80; PAE: 1.0, 2.0	7 interactions	T84-W88, T84-F78, T84-N80, T84-A74, T84-R75; PAE: 1.0, 2.5, 2.0, 2.0, 2.0									1 mutation(s) (Thr84Lys: 1.347)	1.017		0.833		0.812		0.392		0.807
85	T	Threonine	Polar/Neutral	Helix	H (helix)	H (α-helix)	50	-67.7	-42.7	85.71			Coagulation factor IX; Coagulation factor IXa light chain						Gla	O-linked (GalNAc...) threonine																						119	-0.7														4 interactions	T85-K89, T85-T81; PAE: 1.0, 1.0	6 interactions	T85-K89, T85-T81; PAE: 1.0, 1.0									1 mutation(s) (Thr85Pro: 1.359)	0.911		0.916		0.862	1 mutation(s) (Thr85Arg: 1.159)	0.901		0.847
86	E	Glutamic Acid	Negatively-charged	Helix	H (helix)	H (α-helix)	135	-59.2	-48.8	83.86		Ca(2+); Mg(2+)	Coagulation factor IX; Coagulation factor IXa light chain						Gla					4-carboxyglutamate																		146	-3.5															E86-E82; PAE: 1.0		E86-Q90, E86-E82; PAE: 2.0, 1.0									3 mutation(s) (Glu86Ala: 1.364, Glu86Gly: 1.370, Glu86His: 1.381)	1.187	4 mutation(s) (Glu86His: 1.182, Glu86Ile: 1.193, Glu86Lys: 1.210, Glu86Ala: 1.223)	1.006	2 mutation(s) (Glu86Gln: 1.136, Glu86Thr: 1.157)	0.939		0.797	3 mutation(s) (Glu86Ala: 1.258, Glu86Gln: 1.265, Glu86Thr: 1.293)	1.064
87	F	Phenylalanine	Aromatic	Helix	H (helix)	H (α-helix)	27	-60.4	-45.4	83.86			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							165	2.8												Pocket 5: Mean pLDDT: 74.14, Volume: 208.89 Å³, Druggability score: 0.02	0.0171	3 interactions	F87-Y91, F87-R83; PAE: 1.0, 1.0	5 interactions	F87-Y91, F87-R83; PAE: 1.0, 1.0									9 mutation(s) (Phe87Thr: 1.336, Phe87Asn: 1.338, Phe87Met: 1.347, Phe87Ala: 1.350, Phe87Pro: 1.366, Phe87Asp: 1.376, Phe87Ser: 1.384, Phe87Arg: 1.455, Phe87His: 1.458)	1.270	5 mutation(s) (Phe87Thr: 1.189, Phe87Gly: 1.210, Phe87Asp: 1.218, Phe87Ser: 1.225, Phe87Pro: 1.239)	1.073	11 mutation(s) (Phe87Lys: 1.133, Phe87Arg: 1.142, Phe87Asp: 1.153, Phe87Gln: 1.155, Phe87Ala: 1.158, Phe87Asn: 1.166, Phe87His: 1.171, Phe87Thr: 1.179, Phe87Ser: 1.180, Phe87Pro: 1.193, Phe87Gly: 1.200)	1.073		0.214	7 mutation(s) (Phe87Asp: 1.255, Phe87Gln: 1.255, Phe87Ser: 1.256, Phe87His: 1.260, Phe87Gly: 1.263, Phe87Pro: 1.265, Phe87Thr: 1.269)	1.161
88	W	Tryptophan	Aromatic	Helix	H (helix)	H (α-helix)	59	-68.5	-33.9	83.88			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							204	-0.9														4 interactions	W88-T84, W88-V92; PAE: 1.0, 1.0	6 interactions	W88-T84, W88-V92; PAE: 1.0, 1.0									9 mutation(s) (Trp88His: 1.359, Trp88Glu: 1.389, Trp88Asn: 1.400, Trp88Asp: 1.414, Trp88Ser: 1.423, Trp88Arg: 1.433, Trp88Ala: 1.445, Trp88Pro: 1.485, Trp88Gln: 1.525)	1.282	11 mutation(s) (Trp88Glu: 1.173, Trp88Gly: 1.175, Trp88Leu: 1.177, Trp88Gln: 1.178, Trp88Asn: 1.181, Trp88Met: 1.220, Trp88His: 1.239, Trp88Arg: 1.247, Trp88Pro: 1.261, Trp88Ser: 1.272, Trp88Thr: 1.274)	1.101	12 mutation(s) (Trp88Gln: 1.140, Trp88Thr: 1.141, Trp88Glu: 1.148, Trp88Leu: 1.155, Trp88Val: 1.165, Trp88Ser: 1.169, Trp88Met: 1.175, Trp88His: 1.190, Trp88Gly: 1.191, Trp88Arg: 1.196, Trp88Asn: 1.201, Trp88Pro: 1.211)	1.108		0.357	9 mutation(s) (Trp88Gln: 1.257, Trp88Glu: 1.258, Trp88Gly: 1.282, Trp88Ser: 1.285, Trp88Asn: 1.294, Trp88Met: 1.297, Trp88Thr: 1.322, Trp88Pro: 1.323, Trp88Asp: 1.340)	1.220
89	K	Lysine	Positively-charged	Helix	H (helix)	H (α-helix)	36	-53.7	-64.1	84.01			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							147	-3.9														2 interactions	K89-D93, K89-T85, K89-D111; PAE: 2.5, 1.0, 2.0	4 interactions	K89-D93, K89-T85; PAE: 2.5, 1.0										0.930		0.898		0.909		0.896	1 mutation(s) (Lys89Pro: 1.269)	0.941
90	Q	Glutamine	Polar/Neutral	Helix	H (helix)	H (α-helix)	115	-59.2	-36.3	82.07			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							146	-3.5												Pocket 5: Mean pLDDT: 74.14, Volume: 208.89 Å³, Druggability score: 0.02	0.0171		Q90-G94; PAE: 2.0		Q90-G94, Q90-E86; PAE: 2.0, 2.0										0.975		0.946		0.920		0.930		0.949
91	Y	Tyrosine	Aromatic		H (helix)	H (α-helix)	45	-68.9	-33.9	82.26			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							181	-1.3												Pocket 5: Mean pLDDT: 74.14, Volume: 208.89 Å³, Druggability score: 0.02	0.0171	5 interactions	Y91-F87, Y91-C69; PAE: 1.0, 3.0	3 interactions	Y91-F87; PAE: 1.0										1.109	2 mutation(s) (Tyr91Gln: 1.208, Tyr91Lys: 1.229)	0.982	1 mutation(s) (Tyr91Gln: 1.132)	0.949		0.607		1.041
92	V	Valine	Aliphatic		H (helix)	H (α-helix)	85	-84.5	-40.6	82.62			Coagulation factor IX; Coagulation factor IXa light chain						Gla																							117	4.2														1 interaction	V92-W88; PAE: 1.0	3 interactions	V92-W88; PAE: 1.0									1 mutation(s) (Val92Glu: 1.338)	0.994		1.009		0.976		0.969		1.010
93	D	Aspartic Acid	Negatively-charged		H (helix)	H (α-helix)	40	-130.7	-2.4	83.67		Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							132	-3.5														2 interactions	D93-K89, D93-N113; PAE: 2.5, 2.0	2 interactions	D93-K89, D93-N113; PAE: 2.5, 2.0					1 interaction	1 interaction			1 mutation(s) (Asp93Pro: 1.341)	1.121	3 mutation(s) (Asp93Ser: 1.177, Asp93Thr: 1.196, Asp93Pro: 1.228)	1.036		0.890		0.951		0.667
94	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	C (loop/coil)	29	84.6	164.6	83.51		Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							75	-0.4														1 interaction	G94-Q90; PAE: 2.0		G94-Q90; PAE: 2.0										0.995		0.921		0.961		0.976		0.898
95	D	Aspartic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	61	-71.8	106.6	84.78			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							132	-3.5																											1.123	1 mutation(s) (Asp95Ala: 1.226)	1.031		0.901		0.948		0.696
96	Q	Glutamine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	58	-67.2	-15.9	87.32		Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							146	-3.5														3 interactions	Q96-D110; PAE: 2.0	3 interactions	Q96-S114; PAE: 2.0						2 interactions				1.121	2 mutation(s) (Gln96His: 1.183, Gln96Glu: 1.184)	1.042	3 mutation(s) (Gln96Ala: 1.137, Gln96Glu: 1.168, Gln96Asp: 1.200)	1.005		0.994		0.820
97	C	Cysteine	Special, a very reactive sulfhydryl group	Turn	C (loop/coil)	T (turn)	18	-84.9	-9.9	93.08			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 97-108		EGF-like 1; calcium-binding																							121	2.5														3 interactions		7 interactions	C97-K109, C97-D110; PAE: 1.0, 1.5						2 interactions				0.492		0.148	2 mutation(s) (Cys97Tyr: -0.005, Cys97His: -0.002)	0.056		0.176	1 mutation(s) (Cys97Tyr: -0.003)	0.068
98	E	Glutamic Acid	Negatively-charged	Turn	C (loop/coil)	T (turn)	158	-58.5	-33.4	90.38			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							146	-3.5														7 interactions		7 interactions											1.039		0.998		0.934		0.954		0.882
99	S	Serine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	93	-72.0	-4.2	90.82			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding	O-linked (Glc...) serine																						105	-0.8																4 interactions						2 interactions	2 interactions				1.118		1.059		0.981		0.987		0.771
100	N	Asparagine	Polar/Neutral		C (loop/coil)	C (loop/coil)	132	49.7	58.5	92.82			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							132	-3.5														8 interactions		7 interactions						11 interactions	4 interactions				0.991		0.933		0.817		0.923		0.779
101	P	Proline	Special, No backbone hydrogen		C (loop/coil)	C (loop/coil)	13	-69.7	-24.4	95.06			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							115	1.6																4 interactions	P101-N127; PAE: 1.5										1.029		0.640		0.313		0.557		0.163
102	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	C (loop/coil)	C (loop/coil)	17	-80.6	119.0	96.08			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 102-117		EGF-like 1; calcium-binding																							121	2.5																2 interactions						10 interactions					0.150	1 mutation(s) (Cys102Tyr: -0.005)	0.067	3 mutation(s) (Cys102Ala: -0.019, Cys102Ser: -0.007, Cys102Phe: -0.005)	0.057		0.093	5 mutation(s) (Cys102Pro: -0.017, Cys102Ala: -0.015, Cys102Asp: -0.007, Cys102Thr: -0.004, Cys102Gln: -0.003)	0.057
103	L	Leucine	Aliphatic	Beta strand	C (loop/coil)	C (loop/coil)	87	-88.6	174.5	92.91			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							131	3.8														13 interactions	L103-N127; PAE: 1.0												0.953		0.934		0.814		0.922		0.812
104	N	Asparagine	Polar/Neutral	Beta strand	C (loop/coil)	T (turn)	86	54.6	25.3	89.89			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							132	-3.5														10 interactions	N104-C128; PAE: 1.0	7 interactions						5 interactions	6 interactions				0.887	1 mutation(s) (Asn104His: 1.189)	0.497	4 mutation(s) (Asn104Thr: -0.008, Asn104Pro: -0.004, Asn104Cys: -0.004, Asn104Val: -0.003)	0.230		0.439	1 mutation(s) (Asn104Cys: -0.022)	0.172
105	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	C (loop/coil)	T (turn)	67	83.0	19.1	89.49			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							75	-0.4																7 interactions						2 interactions	3 interactions				0.939		0.750	1 mutation(s) (Gly105Val: -0.013)	0.433		0.671	1 mutation(s) (Gly105Val: -0.019)	0.386
106	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		H (helix)	P (polyproline helix)	16	-62.9	142.0	93.48			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							75	-0.4														8 interactions		1 interaction											0.655		0.253	3 mutation(s) (Gly106Tyr: -0.007, Gly106Phe: -0.005, Gly106Gln: -0.003)	0.112		0.282		0.118
107	S	Serine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	73	-87.5	133.5	95.65			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding	O-linked (Fuc...) serine																						105	-0.8														13 interactions	S107-W118; PAE: 1.0	6 interactions	S107-W118; PAE: 1.0					2 interactions	8 interactions				0.950		0.891		0.772		0.875		0.816
108	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	B (undefined)	E (parallel sheets)	46	-99.5	137.0	95.72			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 97-108		EGF-like 1; calcium-binding																							121	2.5																2 interactions						2 interactions	1 interaction				0.349	1 mutation(s) (Cys108Glu: -0.003)	0.104	1 mutation(s) (Cys108Ala: -0.005)	0.066		0.134	3 mutation(s) (Cys108Ser: -0.019, Cys108Glu: -0.013, Cys108Trp: -0.004)	0.066
109	K	Lysine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	106	-121.4	126.6	93.11			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							147	-3.9														13 interactions	K109-E116; PAE: 1.0	15 interactions	K109-C97, K109-E116; PAE: 1.0, 1.0										0.944		0.844		0.736		0.856		0.723
110	D	Aspartic Acid	Negatively-charged	Beta strand	B (undefined)	E (parallel sheets)	30	-72.1	143.4	87.17		Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding					(3R)-3-hydroxyaspartate																		132	-3.5							dbSNP: rs137852274; Variant type: LP/P; AA change: Asp110Asn; PTM type: Phosphorylation; PTM morphology: KD*DINsYECWC; Var class: II							5 interactions	D110-Q96; PAE: 2.0	5 interactions	D110-C97; PAE: 1.5					5 interactions	3 interactions			2 mutation(s) (Asp110Gly: 1.356, Asp110Lys: 1.359)	1.153	7 mutation(s) (Asp110Thr: 1.169, Asp110Ala: 1.172, Asp110Pro: 1.179, Asp110His: 1.180, Asp110Gln: 1.192, Asp110Gly: 1.196, Asp110Lys: 1.206)	1.078	1 mutation(s) (Asp110Ser: 1.135)	0.924		0.967		0.706
111	D	Aspartic Acid	Negatively-charged	Beta strand	B (undefined)	E (parallel sheets)	66	-147.8	167.4	85.08		Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							132	-3.5														8 interactions	D111-K89; PAE: 2.0								1 interaction				1.048		0.983		0.799		0.926	1 mutation(s) (Asp111Gln: 1.274)	0.838
112	I	Isoleucine	Aliphatic		C (loop/coil)	T (turn)	87	-64.1	122.2	83.91			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							131	4.5							dbSNP: -; Variant type: LP/P; AA change: Ile112Ser; PTM type: Phosphorylation; PTM morphology: KDDI*NsYECWC; Var class: II																				1.163	6 mutation(s) (Ile112Thr: 1.169, Ile112His: 1.169, Ile112Gln: 1.172, Ile112Glu: 1.182, Ile112Ser: 1.190, Ile112Gly: 1.229)	1.084	1 mutation(s) (Ile112Gly: 1.134)	1.012		0.999		0.872
113	N	Asparagine	Polar/Neutral		C (loop/coil)	T (turn)	133	50.5	21.3	84.35			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							132	-3.5							dbSNP: -; Variant type: LP/P; AA change: Asn113Lys; PTM type: Phosphorylation; PTM morphology: KDDIN*sYECWC; Var class: II							2 interactions	N113-D93; PAE: 2.0	3 interactions	N113-D93; PAE: 2.0					1 interaction					0.977		0.920		0.864		0.890		0.754
114	S	Serine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	42	-160.2	173.5	90.49			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding					Phosphoserine																		105	-0.8						Morphology: SCKDDINsYECWCPF; Domain: EGF										9 interactions	S114-Q96; PAE: 2.0										1.017		0.956	1 mutation(s) (Ser114Gly: 1.164)	0.795		0.922		0.791
115	Y	Tyrosine	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	47	-138.9	155.6	91.79			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							181	-1.3							dbSNP: rs1603264727; Variant type: LP/P; AA change: Tyr115Cys; PTM type: Phosphorylation; PTM morphology: KDDINsY*ECWC; Var class: II							5 interactions	Y115-N127; PAE: 1.5	1 interaction						3 interactions					1.104		0.538	1 mutation(s) (Tyr115Asp: -0.004)	0.215		0.477		0.181
116	E	Glutamic Acid	Negatively-charged	Beta strand	B (undefined)	E (parallel sheets)	103	-112.9	119.0	94.28			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							146	-3.5														13 interactions	E116-K109; PAE: 1.0	6 interactions	E116-K109; PAE: 1.0										1.037		0.991		0.339		0.939		0.838
117	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	B (undefined)	E (parallel sheets)	22	-91.6	124.1	95.94			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 102-117		EGF-like 1; calcium-binding																							121	2.5																1 interaction											0.349	1 mutation(s) (Cys117Phe: -0.004)	0.105	4 mutation(s) (Cys117Arg: -0.006, Cys117Asn: -0.005, Cys117Pro: -0.005, Cys117Trp: -0.004)	0.056		0.124	3 mutation(s) (Cys117Leu: -0.004, Cys117His: -0.003, Cys117Met: -0.002)	0.064
118	W	Tryptophan	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	146	-91.8	100.1	94.14			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							204	-0.9														13 interactions	W118-S107; PAE: 1.0	13 interactions	W118-S107; PAE: 1.0										1.017		0.981		0.063		0.991		1.075
119	C	Cysteine	Special, a very reactive sulfhydryl group		H (helix)	P (polyproline helix)	42	-77.3	137.6	90.44			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 119-128		EGF-like 1; calcium-binding																							121	2.5							dbSNP: -; Variant type: LP/P; AA change: Cys119Phe; PTM type: Phosphorylation; PTM morphology: KDDINsYECWC*; Var class: II&-					Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115			12 interactions	C119-C128; PAE: 2.0	1 interaction									0.424		0.130	4 mutation(s) (Cys119Arg: -0.009, Cys119Leu: -0.008, Cys119Ser: -0.003, Cys119Tyr: -0.003)	0.060		0.152	5 mutation(s) (Cys119His: -0.012, Cys119Ile: -0.009, Cys119Arg: -0.008, Cys119Trp: -0.005, Cys119Leu: -0.004)	0.068
120	P	Proline	Special, No backbone hydrogen		H (helix)	P (polyproline helix)	47	-66.0	161.6	86.43			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							115	1.6												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115														0.927		0.871		0.630		0.864		0.766
121	F	Phenylalanine	Aromatic		C (loop/coil)	T (turn)	151	-55.5	125.0	77.81			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							165	2.8												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115														0.994		1.011		0.647		0.991		1.041
122	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	T (turn)	24	102.4	-3.3	76.03			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							75	-0.4												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115	3 interactions	G122-V132; PAE: 4.0	3 interactions	G122-V132; PAE: 4.0										0.890		0.640	1 mutation(s) (Gly122Cys: -0.007)	0.420		0.677		0.469
123	F	Phenylalanine	Aromatic		B (undefined)	E (parallel sheets)	61	-123.6	149.3	84.06			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							165	2.8												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115														1.058		0.753		0.477		0.713		0.430
124	E	Glutamic Acid	Negatively-charged		B (undefined)	E (parallel sheets)	16	-145.1	-179.5	83.52			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							146	-3.5														14 interactions	E124-L130, E124-R140; PAE: 1.0, 6.5	16 interactions	E124-L130, E124-C128, E124-E129; PAE: 1.0, 1.5, 1.0										1.033		0.977		0.437		0.917		0.694
125	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Turn	C (loop/coil)	S (bend)	33	105.1	170.0	86.78			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							75	-0.4																											0.560		0.187	3 mutation(s) (Gly125Leu: -0.008, Gly125Thr: -0.004, Gly125Tyr: -0.004)	0.054		0.214		0.065
126	K	Lysine	Positively-charged	Turn	C (loop/coil)	T (turn)	140	-61.1	-30.9	90.91			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							147	-3.9														1 interaction													1.005		0.989		0.922		0.994		0.976
127	N	Asparagine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	43	-119.3	16.4	94.1			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							132	-3.5														8 interactions	N127-Y115, N127-L103; PAE: 1.5, 1.0	6 interactions	N127-P101; PAE: 1.5					1 interaction					1.028		0.912		0.700		0.874		0.639
128	C	Cysteine	Special, a very reactive sulfhydryl group	Turn	C (loop/coil)	S (bend)	0	58.3	27.7	92.32			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 119-128		EGF-like 1; calcium-binding																							121	2.5														2 interactions	C128-N104; PAE: 1.0	13 interactions	C128-E124, C128-C119; PAE: 1.5, 2.0	1 interaction									0.533		0.169	1 mutation(s) (Cys128Tyr: -0.002)	0.049		0.195		0.064
129	E	Glutamic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	87	-80.3	-19.6	89.28			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 1; calcium-binding																							146	-3.5														6 interactions		13 interactions	E129-E124; PAE: 1.0										0.934		0.580		0.320		0.526		0.240
130	L	Leucine	Aliphatic		B (undefined)	E (parallel sheets)	75	-95.7	128.9	82.77			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							131	3.8														12 interactions	L130-E124; PAE: 1.0	13 interactions	L130-E124; PAE: 1.0										1.043		1.009		0.977		0.984		0.917
131	D	Aspartic Acid	Negatively-charged		B (undefined)	E (parallel sheets)	75	-77.5	124.3	79.79			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							132	-3.5												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115														0.939		0.968		0.875		0.990		1.024
132	V	Valine	Aliphatic		C (loop/coil)	C (loop/coil)	12	-74.4	95.7	76.97			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							117	4.2												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115		V132-G122; PAE: 4.0		V132-G122; PAE: 4.0										0.760		1.004	1 mutation(s) (Val132Val: 1.148)	1.148		1.066		1.061
133	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	29	-104.9	162.2	81.74			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							119	-0.7														3 interactions		4 interactions	T133-G139; PAE: 3.5										1.034	2 mutation(s) (Thr133Pro: 1.184, Thr133Lys: 1.198)	1.053		0.947		0.940		0.715
134	C	Cysteine	Special, a very reactive sulfhydryl group	Turn	C (loop/coil)	T (turn)	19	-59.0	-21.4	85.56			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 134-145		EGF-like 2																							121	2.5														4 interactions	C134-N147; PAE: 3.5	15 interactions	C134-N147, C134-N138, C134-G139, C134-K146; PAE: 3.5, 2.0, 2.0, 2.5										0.419		0.337		0.349		0.301		0.117
135	N	Asparagine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	148	-74.6	-17.9	81.49			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							132	-3.5																											1.084	1 mutation(s) (Asn135Thr: 1.254)	1.023		0.958		0.979		0.828
136	I	Isoleucine	Aliphatic	Turn	C (loop/coil)	T (turn)	63	-109.4	114.7	78.46			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							131	4.5														1 interaction		4 interactions											1.023		0.991		0.953		0.967		0.888
137	K	Lysine	Positively-charged	Helix	H (helix)	G (3₁₀-helix)	147	48.3	37.5	80.05			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							147	-3.9																											1.017		0.963	1 mutation(s) (Lys137Asp: 1.134)	0.936		0.957		0.855
138	N	Asparagine	Polar/Neutral	Helix	H (helix)	G (3₁₀-helix)	48	53.4	31.0	86.36			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							132	-3.5														7 interactions	N138-Q143; PAE: 2.0	12 interactions	N138-C134, N138-C145; PAE: 2.0, 1.5					12 interactions					1.023		0.896		0.694		0.735		0.362
139	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Helix	H (helix)	G (3₁₀-helix)	0	58.4	23.1	85.38			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							75	-0.4														4 interactions	G139-K168; PAE: 2.0	13 interactions	G139-C134, G139-T133; PAE: 2.0, 3.5																		
140	R	Arginine	Positively-charged	Helix	H (helix)	G (3₁₀-helix)	138	60.3	14.6	85.92			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							175	-4.5												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115	1 interaction	R140-E124; PAE: 6.5	5 interactions											1.047		0.983		0.897		0.917		0.738
141	C	Cysteine	Special, a very reactive sulfhydryl group		C (loop/coil)	C (loop/coil)	8	-71.9	132.6	90.68			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 141-155		EGF-like 2																							121	2.5																9 interactions	C141-C155; PAE: 2.5									14 mutation(s) (Cys141His: -0.037, Cys141Tyr: -0.036, Cys141Glu: -0.030, Cys141Lys: -0.026, Cys141Val: -0.023, Cys141Gln: -0.023, Cys141Thr: -0.022, Cys141Ser: -0.019, Cys141Ala: -0.016, Cys141Asp: -0.013, Cys141Arg: -0.013, Cys141Gly: -0.009, Cys141Leu: -0.006, Cys141Met: -0.005)	0.049	10 mutation(s) (Cys141His: -0.017, Cys141Arg: -0.013, Cys141Met: -0.012, Cys141Val: -0.010, Cys141Ile: -0.007, Cys141Ser: -0.006, Cys141Tyr: -0.005, Cys141Gly: -0.003, Cys141Pro: -0.001, Cys141Asp: -0.000)	0.054	3 mutation(s) (Cys141Thr: -0.005, Cys141Ser: -0.003, Cys141Phe: -0.002)	0.057		0.058	3 mutation(s) (Cys141Arg: -0.012, Cys141Gly: -0.006, Cys141Thr: -0.002)	0.057
142	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	S (bend)	50	-63.3	-37.9	91.63			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							146	-3.5														13 interactions	E142-C170, E142-K168; PAE: 1.5, 2.0	13 interactions	E142-C170, E142-S169; PAE: 1.5, 2.0										0.735		0.748		0.696		0.779		0.667
143	Q	Glutamine	Polar/Neutral	Beta strand	C (loop/coil)	S (bend)	1	-118.6	-83.1	91.23			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							146	-3.5														13 interactions	Q143-N138, Q143-T158; PAE: 2.0, 2.0	12 interactions	Q143-T158; PAE: 2.0									4 mutation(s) (Gln143Cys: -0.052, Gln143Trp: -0.014, Gln143Ser: 0.001, Gln143Asp: 0.003)	0.215	2 mutation(s) (Gln143Cys: -0.020, Gln143Arg: -0.004)	0.184		0.203		0.224	3 mutation(s) (Gln143Asp: -0.020, Gln143Pro: -0.005, Gln143Cys: -0.002)	0.167
144	F	Phenylalanine	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	17	-110.9	126.8	92.83			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							165	2.8												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	12 interactions	F144-S156; PAE: 1.5	13 interactions	F144-T158, F144-Y341, F144-S156; PAE: 2.0, 2.5, 1.5						12 interactions			7 mutation(s) (Phe144Cys: -0.039, Phe144Glu: -0.031, Phe144Ala: -0.021, Phe144Pro: -0.019, Phe144Arg: -0.004, Phe144Asp: 0.002, Phe144Ser: 0.005)	0.232	5 mutation(s) (Phe144Glu: -0.009, Phe144Pro: -0.007, Phe144Thr: -0.001, Phe144Asp: -0.000, Phe144Cys: -0.000)	0.228		0.204		0.236	4 mutation(s) (Phe144Glu: -0.011, Phe144Arg: -0.009, Phe144Pro: -0.003, Phe144Ala: -0.002)	0.161
145	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	B (undefined)	E (parallel sheets)	9	-113.7	126.7	91.13			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 134-145		EGF-like 2																							121	2.5															C145-Y341; PAE: 4.0		C145-N138; PAE: 1.5					12 interactions				1 mutation(s) (Cys145Pro: -0.013)	0.355	1 mutation(s) (Cys145Asp: -0.001)	0.169		0.183		0.184	1 mutation(s) (Cys145Asp: -0.004)	0.076
146	K	Lysine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	107	-124.1	137.7	91.17			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							147	-3.9														12 interactions	K146-V154; PAE: 2.0	13 interactions	K146-V154, K146-C134; PAE: 2.0, 2.5										0.935		0.909		0.907		0.922		0.903
147	N	Asparagine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	70	-78.1	125.6	87.58			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							132	-3.5														4 interactions	N147-C134; PAE: 3.5	11 interactions	N147-C134; PAE: 3.5										1.010		1.006		1.007		0.997		0.986
148	S	Serine	Polar/Neutral	Beta strand	C (loop/coil)	C (loop/coil)	53	-66.7	172.4	85.45			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							105	-0.8														10 interactions	S148-K152; PAE: 5.5	11 interactions											0.969		0.975		0.930		0.925		0.869
149	A	Alanine	Aliphatic	Turn	C (loop/coil)	T (turn)	102	-55.6	-31.3	84.59			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							89	1.8																											0.952		0.947		0.942		0.955		0.951
150	D	Aspartic Acid	Negatively-charged	Turn	C (loop/coil)	T (turn)	120	-89.1	19.0	82.83			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							132	-3.5												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115														0.943		0.956		0.964		0.936		0.915
151	N	Asparagine	Polar/Neutral	Turn	C (loop/coil)	S (bend)	105	58.4	8.3	76.43			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							132	-3.5												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115	2 interactions		2 interactions											0.925		0.940		0.930		0.948		0.953
152	K	Lysine	Positively-charged	Beta strand	C (loop/coil)	C (loop/coil)	138	-70.8	138.1	83.2			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							147	-3.9												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115	11 interactions	K152-S148; PAE: 5.5	6 interactions											1.039		0.989		0.959		0.965		0.895
153	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	17	-70.5	126.0	88.04			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							117	4.2												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115			11 interactions											1.001		1.008		0.895		0.852		0.643
154	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	75	-116.4	119.0	92.47			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							117	4.2														12 interactions	V154-K146; PAE: 2.0	12 interactions	V154-K146; PAE: 2.0										0.960		0.922		0.918		0.912		0.874
155	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	B (undefined)	E (parallel sheets)	10	-91.4	148.9	93.62			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 141-155		EGF-like 2																							121	2.5																10 interactions	C155-C141, C155-K168; PAE: 2.5, 1.5									2 mutation(s) (Cys155Ala: -0.003, Cys155Lys: 0.001)	0.076		0.072	1 mutation(s) (Cys155Thr: -0.003)	0.065		0.063	2 mutation(s) (Cys155Asn: -0.004, Cys155Thr: -0.003)	0.064
156	S	Serine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	42	-145.5	157.9	94.74			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							105	-0.8														12 interactions	S156-F144; PAE: 1.5	12 interactions	S156-F144; PAE: 1.5										0.873		0.847		0.829		0.853		0.811
157	C	Cysteine	Special, a very reactive sulfhydryl group		C (loop/coil)	C (loop/coil)	28	-116.1	158.3	94.4			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 157-170		EGF-like 2																							121	2.5												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107			7 interactions	C157-L163; PAE: 1.0									1 mutation(s) (Cys157Thr: 0.005)	0.086	1 mutation(s) (Cys157Arg: 0.001)	0.070		0.065		0.062		0.064
158	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	15	-71.7	162.9	92.85			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							119	-0.7												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	12 interactions	T158-Q143; PAE: 2.0	13 interactions	T158-F144, T158-Q143; PAE: 2.0, 2.0										0.726		0.700		0.666		0.680		0.622
159	E	Glutamic Acid	Negatively-charged		C (loop/coil)	T (turn)	105	-54.4	138.6	91.03			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							146	-3.5												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107				E159-T461; PAE: 9.5										0.830		0.862		0.825		0.853		0.844
160	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	T (turn)	18	87.4	-4.0	93.03			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							75	-0.4												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	12 interactions	G160-A173; PAE: 2.0	13 interactions	G160-A173, G160-V174; PAE: 2.0, 2.0										0.420		0.350		0.337		0.346		0.289
161	Y	Tyrosine	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	24	-121.4	150.1	95.8			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							181	-1.3														12 interactions	Y161-C178; PAE: 1.5												0.327	1 mutation(s) (Tyr161Cys: -0.005)	0.249		0.250		0.256	1 mutation(s) (Tyr161Asn: -0.004)	0.232
162	R	Arginine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	150	-115.5	144.1	95.8			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							175	-4.5														12 interactions	R162-E171; PAE: 1.0	12 interactions	R162-E171; PAE: 1.0										0.906		0.898		0.873		0.892		0.847
163	L	Leucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	55	-69.3	126.7	96.0			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							131	3.8																11 interactions	L163-C157; PAE: 1.0										0.464		0.374		0.359		0.377		0.317
164	A	Alanine	Aliphatic		C (loop/coil)	C (loop/coil)	7	-68.7	169.0	95.1			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							89	1.8														12 interactions	A164-S169; PAE: 2.5												0.797		0.757		0.729		0.763		0.715
165	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	T (turn)	191	-60.6	-29.4	94.14			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							146	-3.5																											0.954		0.972		0.973		0.948		0.983
166	N	Asparagine	Polar/Neutral	Beta strand	C (loop/coil)	T (turn)	84	-68.3	-3.7	90.75			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							132	-3.5																											0.476		0.292		0.286		0.261		0.224
167	Q	Glutamine	Polar/Neutral	Beta strand	C (loop/coil)	S (bend)	110	60.2	19.3	91.72			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							146	-3.5																6 interactions											0.891		0.850		0.844		0.828		0.830
168	K	Lysine	Positively-charged	Beta strand	C (loop/coil)	S (bend)	26	-130.2	-43.3	90.88			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							147	-3.9												Pocket 3: Mean pLDDT: 76.99, Volume: 738.09 Å³, Druggability score: 0.11	0.1115	13 interactions	K168-G139, K168-E142; PAE: 2.0, 2.0	7 interactions	K168-C155; PAE: 1.5										0.929		0.873		0.853		0.813		0.788
169	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	39	-86.6	153.7	94.44			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							105	-0.8														12 interactions	S169-A164; PAE: 2.5	4 interactions	S169-E142; PAE: 2.0										0.860		0.851		0.821		0.788		0.812
170	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	B (undefined)	E (parallel sheets)	6	-115.1	105.3	95.58			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 157-170		EGF-like 2																							121	2.5														11 interactions	C170-E142; PAE: 1.5	12 interactions	C170-E142; PAE: 1.5									1 mutation(s) (Cys170Thr: 0.006)	0.134	1 mutation(s) (Cys170Tyr: -0.003)	0.085		0.084		0.076	2 mutation(s) (Cys170Met: -0.007, Cys170Tyr: -0.002)	0.085
171	E	Glutamic Acid	Negatively-charged	Beta strand	B (undefined)	E (parallel sheets)	78	-90.3	140.2	95.12			Coagulation factor IX; Coagulation factor IXa light chain						EGF-like 2																							146	-3.5														12 interactions	E171-R162; PAE: 1.0	12 interactions	E171-R162; PAE: 1.0										0.928		0.907		0.887		0.853		0.872
172	P	Proline	Special, No backbone hydrogen	Beta strand	B (undefined)	E (parallel sheets)	49	-53.5	120.9	95.24			Coagulation factor IX; Coagulation factor IXa light chain																													115	1.6																											0.824		0.747		0.722		0.673		0.686
173	A	Alanine	Aliphatic		C (loop/coil)	S (bend)	59	-93.9	-14.4	95.28			Coagulation factor IX; Coagulation factor IXa light chain																													89	1.8														12 interactions	A173-G160; PAE: 2.0	12 interactions	A173-G160; PAE: 2.0									1 mutation(s) (Ala173Pro: 0.002)	0.909		0.936		0.912		0.891		0.894
174	V	Valine	Aliphatic	Beta strand	C (loop/coil)	S (bend)	67	-128.3	157.9	95.11			Coagulation factor IX; Coagulation factor IXa light chain																													117	4.2												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107			11 interactions	V174-G160; PAE: 2.0										0.862		0.830		0.813		0.769		0.803
175	P	Proline	Special, No backbone hydrogen	Beta strand	C (loop/coil)	S (bend)	109	-60.0	-37.6	94.18			Coagulation factor IX; Coagulation factor IXa light chain																													115	1.6																											0.866		0.856		0.837		0.802		0.829
176	F	Phenylalanine	Aromatic	Beta strand	C (loop/coil)	S (bend)	66	-125.3	74.2	94.99			Coagulation factor IX; Coagulation factor IXa light chain																													165	2.8												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107			2 interactions	F176-S329; PAE: 1.5						12 interactions				0.760		0.686		0.682		0.626		0.634
177	P	Proline	Special, No backbone hydrogen		C (loop/coil)	C (loop/coil)	1	-71.0	156.6	95.75			Coagulation factor IX; Coagulation factor IXa light chain																													115	1.6												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107														0.312		0.241		0.228		0.206	1 mutation(s) (Pro177Leu: -0.012)	0.199
178	C	Cysteine	Special, a very reactive sulfhydryl group		C (loop/coil)	T (turn)	16	-58.3	152.0	96.38			Coagulation factor IX; Coagulation factor IXa light chain				Disulfide bond 178-335																									121	2.5												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	12 interactions	C178-Y161; PAE: 1.5		C178-C335; PAE: 1.5						12 interactions				0.115	2 mutation(s) (Cys178Trp: -0.029, Cys178Val: -0.009)	0.069		0.072	2 mutation(s) (Cys178Tyr: -0.017, Cys178Leu: -0.011)	0.065		0.075
179	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	T (turn)	0	66.5	4.1	95.5			Coagulation factor IX; Coagulation factor IXa light chain																													75	-0.4															G179-P333, G179-S423; PAE: 1.0, 1.0		G179-C335, G179-S423; PAE: 1.5, 1.0					13 interactions	12 interactions				0.120	2 mutation(s) (Gly179Met: -0.018, Gly179Lys: -0.008)	0.077		0.080	1 mutation(s) (Gly179Met: -0.004)	0.065		0.076
180	R	Arginine	Positively-charged		C (loop/coil)	C (loop/coil)	114	-97.7	127.5	94.08			Coagulation factor IX; Coagulation factor IXa light chain																													175	-4.5																						8 interactions	8 interactions				0.661		0.569		0.589		0.522		0.527
181	V	Valine	Aliphatic		C (loop/coil)	C (loop/coil)	54	-88.3	118.5	92.81			Coagulation factor IX; Coagulation factor IXa light chain																													117	4.2																											0.951		0.951		0.923		0.915		0.926
182	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	48	-90.4	-14.3	84.5			Coagulation factor IX; Coagulation factor IXa light chain																													105	-0.8																2 interactions						12 interactions	12 interactions				0.935		0.903		0.895		0.875		0.883
183	V	Valine	Aliphatic		C (loop/coil)	S (bend)	47	-72.6	115.3	76.81			Coagulation factor IX; Coagulation factor IXa light chain																													117	4.2																											0.971		0.955		0.985		0.952		0.967
184	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	87	-52.6	120.1	60.17			Coagulation factor IX; Coagulation factor IXa light chain																													105	-0.8																2 interactions											0.972		0.947		0.933		0.940		0.929
185	Q	Glutamine	Polar/Neutral		C (loop/coil)	C (loop/coil)	166	-68.6	71.3	52.61			Coagulation factor IX; Coagulation factor IXa light chain																													146	-3.5																1 interaction						3 interactions	2 interactions				0.999		1.010		1.020		0.998		0.987
186	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	98	-73.1	74.9	40.22			Coagulation factor IX; Coagulation factor IXa light chain																													119	-0.7																							1 interaction				0.972		0.959		0.993		0.968		0.959
187	S	Serine	Polar/Neutral	Beta strand	C (loop/coil)	C (loop/coil)	77	-59.8	111.0	42.3			Coagulation factor IX; Coagulation factor IXa light chain																													105	-0.8																											0.967		0.976		0.986		0.982		0.981
188	K	Lysine	Positively-charged	Beta strand	C (loop/coil)	C (loop/coil)	184	-64.0	74.0	32.52			Coagulation factor IX; Coagulation factor IXa light chain																													147	-3.9																1 interaction											1.013		0.985		0.961	2 mutation(s) (Lys188Ala: 1.100, Lys188Pro: 1.102)	0.983		0.960
189	L	Leucine	Aliphatic	Beta strand	C (loop/coil)	C (loop/coil)	150	-84.7	80.9	40.81			Coagulation factor IX; Coagulation factor IXa light chain																													131	3.8																1 interaction											1.009		1.020		1.005		1.016		0.999
190	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	109	-54.1	118.0	33.91			Coagulation factor IX; Coagulation factor IXa light chain																													119	-0.7																											0.998		0.956		0.948		0.947		0.929
191	R	Arginine	Positively-charged		C (loop/coil)	S (bend)	259	-68.1	40.0	42.03			Coagulation factor IX; Coagulation factor IXa light chain																								Cleavage; by factor XIa					175	-4.5																1 interaction											1.012		1.008		1.004	1 mutation(s) (Arg191Pro: 1.100)	0.988		0.978
192	A	Alanine	Aliphatic		C (loop/coil)	C (loop/coil)	67	-130.4	123.3	39.02			Coagulation factor IX																		Activation peptide						Cleavage; by factor XIa					89	1.8																											0.962		0.958		0.971		0.947		0.957
193	E	Glutamic Acid	Negatively-charged		C (loop/coil)	S (bend)	189	87.2	70.6	33.97			Coagulation factor IX																		Activation peptide											146	-3.5																											1.009		0.996		0.986		0.983		0.973
194	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	118	-142.6	101.6	33.7			Coagulation factor IX																		Activation peptide											119	-0.7																											0.986		0.983		1.004		0.970		0.985
195	V	Valine	Aliphatic		C (loop/coil)	C (loop/coil)	132	-66.7	107.7	34.93			Coagulation factor IX																		Activation peptide											117	4.2																											0.972		0.989		1.025		1.000		0.998
196	F	Phenylalanine	Aromatic		C (loop/coil)	C (loop/coil)	177	-52.1	116.1	36.66			Coagulation factor IX																		Activation peptide											165	2.8																											1.010		1.008		1.015		1.017		1.006
197	P	Proline	Special, No backbone hydrogen		C (loop/coil)	C (loop/coil)	107	-69.8	124.3	34.65			Coagulation factor IX																		Activation peptide											115	1.6																											0.931		0.928		0.921		0.905		0.923
198	D	Aspartic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	158	-42.8	117.8	31.73			Coagulation factor IX																		Activation peptide											132	-3.5																											1.008		0.997		0.990		0.970		0.988
199	V	Valine	Aliphatic		C (loop/coil)	C (loop/coil)	132	-132.7	104.0	34.55			Coagulation factor IX																		Activation peptide											117	4.2																											1.018		1.005		0.994		0.988		0.986
200	D	Aspartic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	145	-51.2	141.4	32.45			Coagulation factor IX																		Activation peptide											132	-3.5																											0.972		0.953		0.950		0.923		0.937
201	Y	Tyrosine	Aromatic		C (loop/coil)	C (loop/coil)	232	-52.9	109.8	29.92			Coagulation factor IX											Sulfotyrosine							Activation peptide											181	-1.3																											0.988		0.996		0.999		0.993		1.011
202	V	Valine	Aliphatic		C (loop/coil)	C (loop/coil)	124	-126.2	114.1	32.31			Coagulation factor IX																		Activation peptide											117	4.2																											1.051		0.996		1.011		1.000		1.007
203	N	Asparagine	Polar/Neutral		C (loop/coil)	C (loop/coil)	157	-58.1	118.7	27.07			Coagulation factor IX							N-linked (GlcNAc...) asparagine											Activation peptide											132	-3.5																											0.959		0.884		0.916		0.859		0.938
204	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	102	-157.2	115.2	32.32			Coagulation factor IX											Phosphoserine							Activation peptide											105	-0.8						Morphology: PDVDYVNsTEAETIL																					0.941		0.933		0.956		0.938		0.945
205	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	132	-43.2	126.1	27.61			Coagulation factor IX							O-linked (GalNAc...) threonine; alternate				Phosphothreonine; alternate							Activation peptide											119	-0.7																																			
206	E	Glutamic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	191	172.8	137.7	33.12			Coagulation factor IX																		Activation peptide											146	-3.5																																			
207	A	Alanine	Aliphatic		C (loop/coil)	C (loop/coil)	94	-73.3	138.7	29.4			Coagulation factor IX																		Activation peptide											89	1.8																											0.970		0.979		0.992		0.981		0.990
208	E	Glutamic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	179	179.0	130.5	29.79			Coagulation factor IX																		Activation peptide											146	-3.5																											0.994		0.989		0.974	1 mutation(s) (Glu208Thr: 1.103)	0.974		0.953
209	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	131	14.7	115.7	27.74			Coagulation factor IX																		Activation peptide											119	-0.7																											1.004		1.002		1.007		1.002		1.004
210	I	Isoleucine	Aliphatic		C (loop/coil)	C (loop/coil)	171	-99.6	115.5	32.18			Coagulation factor IX																		Activation peptide											131	4.5																											0.978		0.982		0.989		0.974		0.972
211	L	Leucine	Aliphatic		C (loop/coil)	C (loop/coil)	150	-72.2	128.5	28.42			Coagulation factor IX																		Activation peptide											131	3.8																											0.979		1.001		0.999		0.987		0.999
212	D	Aspartic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	152	-53.4	127.3	26.8			Coagulation factor IX																		Activation peptide											132	-3.5																											0.992		0.974		0.973		0.953		0.973
213	N	Asparagine	Polar/Neutral		C (loop/coil)	C (loop/coil)	144	-149.5	129.7	28.15			Coagulation factor IX							N-linked (GlcNAc...) asparagine											Activation peptide											132	-3.5																											0.951		0.885		0.867		0.829		0.899
214	I	Isoleucine	Aliphatic		C (loop/coil)	C (loop/coil)	143	97.7	89.4	28.52			Coagulation factor IX																		Activation peptide											131	4.5																											0.958		0.972		0.979		0.969		0.983
215	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	118	43.2	111.2	26.72			Coagulation factor IX							O-linked (GalNAc...) threonine											Activation peptide											119	-0.7																											0.893		0.831		0.873		0.794		0.913
216	Q	Glutamine	Polar/Neutral		C (loop/coil)	C (loop/coil)	191	-174.4	139.7	27.41			Coagulation factor IX																		Activation peptide											146	-3.5																											0.955		0.947		0.959		0.941		0.965
217	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	90	77.4	85.1	30.39			Coagulation factor IX																		Activation peptide											105	-0.8																											0.932		0.924		0.934		0.906		0.930
218	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	148	-61.4	81.4	31.37			Coagulation factor IX																		Activation peptide											119	-0.7																											0.976		0.955		0.960		0.928		0.955
219	Q	Glutamine	Polar/Neutral		C (loop/coil)	C (loop/coil)	140	-103.5	105.6	30.2			Coagulation factor IX																		Activation peptide											146	-3.5																											0.938		0.947		0.944		0.931		0.939
220	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	104	-54.2	92.6	27.51			Coagulation factor IX																		Activation peptide											105	-0.8																											0.943		0.922		0.917		0.923		0.918
221	F	Phenylalanine	Aromatic		C (loop/coil)	C (loop/coil)	172	-69.1	85.2	35.64			Coagulation factor IX																		Activation peptide											165	2.8																											0.987		0.983		0.994	1 mutation(s) (Phe221Pro: 1.107)	0.989		0.984
222	N	Asparagine	Polar/Neutral		C (loop/coil)	C (loop/coil)	119	-70.6	67.4	30.07			Coagulation factor IX																		Activation peptide											132	-3.5																											0.961		0.951		0.950		0.949		0.947
223	D	Aspartic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	123	-74.2	90.1	33.9			Coagulation factor IX																		Activation peptide											132	-3.5																											0.995		0.973		0.975		0.948		0.973
224	F	Phenylalanine	Aromatic		C (loop/coil)	C (loop/coil)	162	-63.9	86.0	34.99			Coagulation factor IX																		Activation peptide											165	2.8																											0.919		0.961		0.966	2 mutation(s) (Phe224Thr: 1.105, Phe224Ser: 1.132)	0.956		0.969
225	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	89	-46.8	107.2	28.93			Coagulation factor IX							O-linked (GalNAc...) threonine											Activation peptide											119	-0.7																											0.976		0.986		0.982		0.950		0.968
226	R	Arginine	Positively-charged		C (loop/coil)	S (bend)	75	-94.8	-2.3	43.81			Coagulation factor IX																		Activation peptide						Cleavage; by factor XIa					175	-4.5															R226-D232; PAE: 12.5		R226-Q370; PAE: 12.0										0.972		0.967		0.961		0.958		0.955
227	V	Valine	Aliphatic		B (undefined)	B (beta bridge)	12	-124.5	159.0	47.5			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																		Cleavage; by factor XIa					117	4.2														2 interactions		6 interactions											1.008		1.010		1.006		1.006		1.001
228	V	Valine	Aliphatic		C (loop/coil)	T (turn)	43	-53.6	104.1	50.12			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V228-V359; PAE: 10.5	8 interactions											0.952		0.950		0.953		0.949		0.934
229	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	T (turn)	33	44.0	38.3	57.21			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4																3 interactions											0.999		0.997		0.997		0.998		0.993
230	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		B (undefined)	B (beta bridge)	12	-109.6	179.0	72.69			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4																4 interactions											0.971		0.966		0.976		0.957		0.962
231	E	Glutamic Acid	Negatively-charged		B (undefined)	E (parallel sheets)	120	-124.9	152.5	84.66			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														3 interactions	E231-Y371; PAE: 1.5	4 interactions	E231-Y371; PAE: 1.5										0.936		0.938		0.963		0.951		0.976
232	D	Aspartic Acid	Negatively-charged		B (undefined)	E (parallel sheets)	73	-63.5	125.2	89.2			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5															D232-R226, D232-Q370; PAE: 12.5, 1.0	3 interactions	D232-Q370; PAE: 1.0										0.985		0.999		0.989	1 mutation(s) (Asp232Glu: 1.102)	0.989		0.999
233	A	Alanine	Aliphatic		H (helix)	P (polyproline helix)	4	-68.6	153.5	91.81			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8														4 interactions	A233-L369; PAE: 1.0	5 interactions											0.943		0.832		0.825		0.790		0.821
234	K	Lysine	Positively-charged		H (helix)	P (polyproline helix)	122	-79.8	153.0	92.78			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9																2 interactions							3 interactions				0.969		0.979		0.964	1 mutation(s) (Lys234Tyr: 1.115)	0.955		0.942
235	P	Proline	Special, No backbone hydrogen		C (loop/coil)	T (turn)	56	-51.1	126.1	92.53			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							115	1.6																3 interactions	P235-H282; PAE: 1.0						2 interactions				0.947		0.843		0.839		0.801		0.828
236	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	T (turn)	12	72.4	11.0	93.37			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4																							1 interaction				0.844		0.681		0.702		0.635		0.661
237	Q	Glutamine	Polar/Neutral		C (loop/coil)	S (bend)	42	-68.8	-32.7	94.69			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5																1 interaction							3 interactions				0.942		0.832		0.831		0.820		0.851
238	F	Phenylalanine	Aromatic		C (loop/coil)	S (bend)	17	-122.7	69.7	96.37			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8																											0.734		0.535		0.539		0.495		0.461
239	P	Proline	Special, No backbone hydrogen		C (loop/coil)	T (turn)	2	-68.7	-11.1	97.05			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							115	1.6														3 interactions	P239-T332; PAE: 1.0	5 interactions	P239-T332, P239-V331; PAE: 1.0, 1.0									2 mutation(s) (Pro239Tyr: -0.035, Pro239Glu: 0.001)	0.160	1 mutation(s) (Pro239Glu: -0.013)	0.099	1 mutation(s) (Pro239Glu: -0.015)	0.105	1 mutation(s) (Pro239Glu: -0.010)	0.087	1 mutation(s) (Pro239Glu: -0.013)	0.075
240	W	Tryptophan	Aromatic		C (loop/coil)	T (turn)	2	-87.7	-10.7	97.98			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							204	-0.9														3 interactions	W240-I256; PAE: 1.0	6 interactions	W240-I334, W240-I256; PAE: 1.0, 1.0						1 interaction			3 mutation(s) (Trp240Met: -0.018, Trp240Asn: -0.017, Trp240Glu: 0.001)	0.092	4 mutation(s) (Trp240Cys: -0.012, Trp240Glu: -0.008, Trp240Asn: -0.004, Trp240Leu: -0.002)	0.055	4 mutation(s) (Trp240Asp: -0.028, Trp240Asn: -0.016, Trp240Ser: -0.012, Trp240Leu: -0.010)	0.042	3 mutation(s) (Trp240Asn: -0.020, Trp240Glu: -0.013, Trp240Gln: -0.004)	0.034	2 mutation(s) (Trp240Asn: -0.021, Trp240Asp: -0.016)	0.034
241	Q	Glutamine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	5	-68.6	135.3	96.94			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														3 interactions	Q241-S354; PAE: 1.5	5 interactions	Q241-G254, Q241-S354; PAE: 1.0, 1.5										0.904		0.847		0.834	3 mutation(s) (Gln241Phe: 1.113, Gln241Leu: 1.117, Gln241Met: 1.129)	0.830		0.797
242	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-127.9	156.8	96.65			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V242-G254; PAE: 1.0	8 interactions	V242-G254; PAE: 1.0									3 mutation(s) (Val242Pro: -0.017, Val242Tyr: -0.013, Val242Lys: 0.003)	0.231	2 mutation(s) (Val242Pro: -0.020, Val242Tyr: -0.004)	0.175	4 mutation(s) (Val242Asp: -0.019, Val242Pro: -0.008, Val242Gln: -0.008, Val242Phe: -0.007)	0.161	4 mutation(s) (Val242His: -0.013, Val242Phe: -0.007, Val242Asp: -0.005, Val242Pro: -0.005)	0.149	4 mutation(s) (Val242Asp: -0.032, Val242Met: -0.013, Val242His: -0.010, Val242Lys: -0.003)	0.140
243	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	4	-104.2	139.0	94.49			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V243-V278; PAE: 1.0	7 interactions	V243-V278; PAE: 1.0										0.839		0.780		0.782		0.751	1 mutation(s) (Val243Pro: -0.001)	0.744
244	L	Leucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-102.3	123.6	93.95			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														4 interactions	L244-F251, L244-C252; PAE: 3.5, 1.5	7 interactions	L244-F251, L244-A250, L244-C252; PAE: 3.5, 6.0, 1.5									2 mutation(s) (Leu244Asp: -0.013, Leu244Pro: 0.006)	0.325	1 mutation(s) (Leu244Ser: -0.002)	0.207		0.284		0.256	1 mutation(s) (Leu244Gln: -0.003)	0.254
245	N	Asparagine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	25	-110.4	128.7	91.69			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														4 interactions	N245-A250, N245-T276; PAE: 5.5, 2.0	8 interactions	N245-A250, N245-T276; PAE: 5.5, 2.0										0.885		0.515		0.880		0.851		0.851
246	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	C (loop/coil)	S (bend)	25	-132.1	-123.0	87.02			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429			2 interactions											0.866	2 mutation(s) (Gly246Arg: -0.033, Gly246Trp: -0.010)	0.381		0.771		0.711		0.693
247	K	Lysine	Positively-charged	Beta strand	C (loop/coil)	S (bend)	171	-71.1	-28.0	80.45			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429														0.982		0.675		0.969		0.957		0.954
248	V	Valine	Aliphatic	Beta strand	C (loop/coil)	S (bend)	100	-119.4	135.3	79.91			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429														0.980		0.750		0.983		0.971		0.961
249	D	Aspartic Acid	Negatively-charged		C (loop/coil)	T (turn)	121	-69.5	145.3	77.97			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5																1 interaction											0.925	1 mutation(s) (Asp249Cys: -0.008)	0.166		0.883		0.840		0.857
250	A	Alanine	Aliphatic		C (loop/coil)	T (turn)	20	50.4	47.1	78.84			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8														3 interactions	A250-N245; PAE: 5.5	5 interactions	A250-L244, A250-N245; PAE: 6.0, 5.5										0.958		0.888		0.931		0.915		0.928
251	F	Phenylalanine	Aromatic		C (loop/coil)	C (loop/coil)	56	-84.8	-23.8	83.24			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429	1 interaction	F251-L244; PAE: 3.5	6 interactions	F251-L244; PAE: 3.5										0.916		0.824		0.880		0.845		0.865
252	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	B (undefined)	E (parallel sheets)	8	-149.8	162.1	92.02			Coagulation factor IX; Coagulation factor IXa heavy chain				Disulfide bond 252-268		Peptidase S1																							121	2.5												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429	3 interactions	C252-L244; PAE: 1.5	5 interactions	C252-L244; PAE: 1.5		C252-C268; PAE: 3.5								0.121	2 mutation(s) (Cys252Glu: -0.000, Cys252Pro: 0.001)	0.078	2 mutation(s) (Cys252Lys: -0.005, Cys252Arg: -0.004)	0.074	1 mutation(s) (Cys252Glu: -0.008)	0.069	2 mutation(s) (Cys252Glu: -0.009, Cys252Gly: -0.002)	0.068
253	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	B (undefined)	E (parallel sheets)	1	-97.3	178.1	93.15			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														4 interactions	G253-T264, G253-S411; PAE: 1.0, 2.0	9 interactions	G253-T264, G253-G413; PAE: 1.0, 1.0									1 mutation(s) (Gly253Asn: -0.023)	0.917		0.831		0.837		0.832		0.798
254	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	B (undefined)	E (parallel sheets)	0	-159.6	178.4	96.47			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														3 interactions	G254-V242; PAE: 1.0	7 interactions	G254-Q241, G254-V242; PAE: 1.0, 1.0										0.125		0.085	3 mutation(s) (Gly254Met: -0.017, Gly254Gln: -0.012, Gly254Trp: -0.012)	0.065	2 mutation(s) (Gly254Trp: -0.009, Gly254Asp: -0.004)	0.058	3 mutation(s) (Gly254Thr: -0.015, Gly254Met: -0.011, Gly254Asp: -0.010)	0.060
255	S	Serine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	0	-131.6	133.7	98.18			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8														3 interactions	S255-V263; PAE: 1.0	7 interactions	S255-V263; PAE: 1.0									1 mutation(s) (Ser255Arg: -0.001)	0.543		0.413	1 mutation(s) (Ser255Lys: -0.017)	0.416		0.391	1 mutation(s) (Ser255Pro: -0.003)	0.375
256	I	Isoleucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-70.3	118.7	98.4			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														4 interactions	I256-I334, I256-W240; PAE: 1.0, 1.0	8 interactions	I256-I334, I256-W240; PAE: 1.0, 1.0									2 mutation(s) (Ile256Pro: -0.004, Ile256Trp: -0.002)	0.202		0.157	2 mutation(s) (Ile256Tyr: -0.013, Ile256Phe: -0.006)	0.146		0.136		0.137
257	V	Valine	Aliphatic	Beta strand	C (loop/coil)	C (loop/coil)	4	-89.4	-42.5	97.45			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	3 interactions	V257-W261; PAE: 1.0	6 interactions	V257-V263; PAE: 1.0										0.251	2 mutation(s) (Val257Pro: -0.019, Val257Asn: -0.002)	0.193	2 mutation(s) (Val257Pro: -0.010, Val257His: -0.006)	0.189	2 mutation(s) (Val257Pro: -0.009, Val257His: -0.005)	0.172	1 mutation(s) (Val257His: -0.012)	0.168
258	N	Asparagine	Polar/Neutral	Beta strand	C (loop/coil)	S (bend)	22	-157.3	-170.5	95.92			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	3 interactions		1 interaction											0.319		0.235	3 mutation(s) (Asn258Pro: -0.013, Asn258Ile: -0.006, Asn258Trp: -0.004)	0.248	1 mutation(s) (Asn258Pro: -0.017)	0.229	2 mutation(s) (Asn258Ile: -0.030, Asn258Pro: -0.012)	0.215
259	E	Glutamic Acid	Negatively-charged		C (loop/coil)	S (bend)	90	-58.7	-25.4	96.55			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	3 interactions	E259-L325; PAE: 1.0	4 interactions	E259-L325; PAE: 1.0										0.791		0.696		0.723		0.672		0.692
260	K	Lysine	Positively-charged		C (loop/coil)	S (bend)	74	-113.6	-14.9	97.33			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9														4 interactions	K260-E320, K260-L321; PAE: 1.0, 1.0	5 interactions	K260-L321; PAE: 1.0				K260-E320; PAE: 1.0						0.609		0.552	1 mutation(s) (Lys260Pro: -0.006)	0.588		0.545		0.532
261	W	Tryptophan	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	17	-122.9	132.6	98.3			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							204	-0.9														3 interactions	W261-V257; PAE: 1.0	8 interactions	W261-E320; PAE: 1.0									2 mutation(s) (Trp261Asp: -0.026, Trp261Cys: 0.001)	0.159	2 mutation(s) (Trp261Asp: -0.011, Trp261Cys: -0.006)	0.125	3 mutation(s) (Trp261Glu: -0.014, Trp261Asn: -0.012, Trp261Pro: -0.009)	0.125	1 mutation(s) (Trp261Arg: -0.004)	0.118	1 mutation(s) (Trp261Glu: -0.011)	0.117
262	I	Isoleucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-115.3	140.5	98.27			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														3 interactions	I262-L319; PAE: 1.0	6 interactions	I262-L319; PAE: 1.0									1 mutation(s) (Ile262Asn: -0.034)	0.211	3 mutation(s) (Ile262Tyr: -0.006, Ile262Gly: -0.002, Ile262Asp: -0.000)	0.166	2 mutation(s) (Ile262Asp: -0.008, Ile262Ser: -0.007)	0.161	3 mutation(s) (Ile262Tyr: -0.008, Ile262Gln: -0.007, Ile262Asn: -0.006)	0.151		0.154
263	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-105.4	139.0	98.2			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V263-S255; PAE: 1.0	8 interactions	V263-S255, V263-V257; PAE: 1.0, 1.0									2 mutation(s) (Val263Asp: -0.006, Val263Pro: -0.003)	0.276		0.233	2 mutation(s) (Val263Pro: -0.011, Val263Lys: -0.003)	0.234	4 mutation(s) (Val263Arg: -0.014, Val263Glu: -0.014, Val263Lys: -0.014, Val263Pro: -0.005)	0.213	1 mutation(s) (Val263Pro: -0.004)	0.205
264	T	Threonine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	0	-151.5	-177.4	96.99			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														5 interactions	T264-G253, T264-A317; PAE: 1.0, 1.0	7 interactions	T264-G253, T264-A317; PAE: 1.0, 1.0									1 mutation(s) (Thr264Gln: -0.003)	0.310		0.258		0.259		0.230	2 mutation(s) (Thr264Gln: -0.003, Thr264Tyr: -0.002)	0.216
265	A	Alanine	Aliphatic		C (loop/coil)	C (loop/coil)	0	-77.4	140.8	96.34			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8																4 interactions	A265-G412; PAE: 1.5										0.391		0.274		0.273		0.243	1 mutation(s) (Ala265Asp: -0.002)	0.221
266	A	Alanine	Aliphatic	Helix	H (helix)	G (3₁₀-helix)	1	-68.0	-29.5	95.85			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8														3 interactions	A266-D315; PAE: 1.0	5 interactions	A266-A317, A266-I316, A266-Y305; PAE: 1.0, 1.0, 1.5										0.318	1 mutation(s) (Ala266Trp: -0.025)	0.206		0.222		0.194	1 mutation(s) (Ala266Ile: -0.008)	0.166
267	H	Histidine	Positively-charged	Helix	H (helix)	G (3₁₀-helix)	29	-70.0	-13.7	92.78	Charge relay system		Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429	3 interactions	H267-D315; PAE: 1.0	3 interactions										1 mutation(s) (His267Pro: -0.014)	0.552		0.404		0.450		0.386		0.379
268	C	Cysteine	Special, a very reactive sulfhydryl group	Helix	H (helix)	G (3₁₀-helix)	7	-80.0	-11.1	92.04			Coagulation factor IX; Coagulation factor IXa heavy chain				Disulfide bond 252-268		Peptidase S1																							121	2.5												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429			2 interactions			C268-C252; PAE: 3.5							3 mutation(s) (Cys268Trp: -0.025, Cys268Ile: -0.018, Cys268Gln: 0.000)	0.094	1 mutation(s) (Cys268Tyr: -0.016)	0.071	1 mutation(s) (Cys268Ile: -0.006)	0.053	2 mutation(s) (Cys268Gly: -0.006, Cys268Arg: -0.005)	0.052	1 mutation(s) (Cys268Arg: -0.005)	0.060
269	V	Valine	Aliphatic	Beta strand	C (loop/coil)	C (loop/coil)	16	-117.9	125.2	91.16			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2																											0.600		0.497		0.562		0.499		0.487
270	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	C (loop/coil)	120	-114.9	136.4	83.48			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429	1 interaction		1 interaction											0.951		0.660		0.977		0.937		0.965
271	T	Threonine	Polar/Neutral	Beta strand	C (loop/coil)	T (turn)	149	-65.6	129.8	78.5			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7																											0.956		0.673		0.965	1 mutation(s) (Thr271Asn: 1.100)	0.959		0.955
272	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	T (turn)	81	90.4	-5.3	81.63			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4																											0.951	1 mutation(s) (Gly272Cys: -0.016)	0.310		0.912		0.897		0.913
273	V	Valine	Aliphatic		C (loop/coil)	C (loop/coil)	31	-87.3	127.3	86.85			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429														0.988		0.442		0.989		0.976		0.971
274	K	Lysine	Positively-charged		C (loop/coil)	C (loop/coil)	152	-70.6	119.2	91.98			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9																1 interaction											0.953		0.425	1 mutation(s) (Lys274Asp: 1.136)	0.906	1 mutation(s) (Lys274Asn: 1.152)	0.884		0.870
275	I	Isoleucine	Aliphatic		C (loop/coil)	C (loop/coil)	3	-109.9	138.3	94.49			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429	2 interactions	I275-V296; PAE: 1.5	4 interactions	I275-V296; PAE: 1.5										0.606	1 mutation(s) (Ile275Lys: -0.009)	0.436		0.533		0.496		0.475
276	T	Threonine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	18	-119.6	136.8	95.6			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														4 interactions	T276-N245; PAE: 2.0	6 interactions	T276-N245; PAE: 2.0										0.845	1 mutation(s) (Thr276Pro: -0.006)	0.740		0.836		0.793		0.802
277	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-102.0	135.5	96.62			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V277-R294; PAE: 1.0	7 interactions	V277-R294; PAE: 1.0									2 mutation(s) (Val277Gly: -0.042, Val277Lys: 0.005)	0.279	1 mutation(s) (Val277Lys: -0.004)	0.233	1 mutation(s) (Val277Trp: -0.004)	0.234	2 mutation(s) (Val277Asn: -0.017, Val277Arg: -0.006)	0.215	1 mutation(s) (Val277Ser: -0.013)	0.213
278	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	9	-118.6	119.1	96.43			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V278-V243; PAE: 1.0	6 interactions	V278-V243; PAE: 1.0									1 mutation(s) (Val278Pro: 0.005)	0.769		0.652	1 mutation(s) (Val278Pro: -0.012)	0.666	1 mutation(s) (Val278Pro: -0.006)	0.626		0.607
279	A	Alanine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-103.4	153.0	97.36			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8														3 interactions	A279-Q292; PAE: 1.0	6 interactions	A279-Q292; PAE: 1.0									1 mutation(s) (Ala279Glu: -0.017)	0.233		0.170		0.165		0.148		0.141
280	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	C (loop/coil)	S (bend)	7	73.7	12.3	95.84			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														3 interactions	G280-T290; PAE: 2.0	6 interactions	G280-T290, G280-E291; PAE: 2.0, 1.0										0.232		0.125		0.137		0.114		0.093
281	E	Glutamic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	25	-74.1	137.2	94.49		Ca(2+)	Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5																1 interaction											0.967		0.969		0.973		0.966		0.984
282	H	Histidine	Positively-charged	Beta strand	C (loop/coil)	S (bend)	24	-128.8	-44.1	93.76			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2														4 interactions	H282-W356, H282-E288, H282-L369; PAE: 1.5, 3.0, 1.0	7 interactions	H282-P235, H282-L369; PAE: 1.0, 1.0										0.941		0.888		0.900		0.877		0.878
283	N	Asparagine	Polar/Neutral	Beta strand	B (undefined)	B (beta bridge)	18	-121.0	105.7	92.28		Ca(2+)	Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														1 interaction	N283-E288; PAE: 3.0	3 interactions											0.950		0.911		0.920		0.903		0.909
284	I	Isoleucine	Aliphatic	Beta strand	C (loop/coil)	T (turn)	56	-58.9	-23.9	88.8			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														3 interactions	I284-L367; PAE: 2.0	1 interaction											0.973		0.905		0.901		0.888		0.893
285	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	T (turn)	145	-85.2	-14.7	86.6			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5																1 interaction											1.000		0.970		0.969		0.952		0.974
286	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	S (bend)	115	-111.5	145.5	88.38		Ca(2+)	Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5																											0.954		0.918		0.934		0.902		0.925
287	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	117	-95.2	97.5	86.74			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7																1 interaction											0.983		0.995		0.988		0.977		0.988
288	E	Glutamic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	42	-81.3	129.7	86.84		Ca(2+)	Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														3 interactions	E288-H282, E288-N283; PAE: 3.0, 3.0	2 interactions											0.952		0.814		0.801		0.778		0.778
289	H	Histidine	Positively-charged		C (loop/coil)	T (turn)	197	-64.4	16.4	90.33			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2																											0.956		0.987		0.959	1 mutation(s) (His289Met: 1.101)	0.970		0.964
290	T	Threonine	Polar/Neutral		C (loop/coil)	T (turn)	29	-93.1	-19.3	94.23			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														3 interactions	T290-G280; PAE: 2.0	4 interactions	T290-G280; PAE: 2.0										0.938		0.844		0.857		0.822		0.838
291	E	Glutamic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	44	-68.4	139.9	96.17		Ca(2+)	Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5																6 interactions	E291-G280; PAE: 1.0										0.727		0.516		0.543		0.561		0.463
292	Q	Glutamine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	21	-123.6	105.2	97.36			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														4 interactions	Q292-V326, Q292-A279; PAE: 1.0, 1.0	5 interactions	Q292-A279; PAE: 1.0																		
293	K	Lysine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	141	-85.1	131.6	96.77			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9																2 interactions											0.912		0.889		0.881		0.845		0.835
294	R	Arginine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	32	-139.5	136.9	97.66			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5														5 interactions	R294-P324, R294-V277; PAE: 1.0, 1.0	7 interactions	R294-V277; PAE: 1.0										0.178		0.112		0.140		0.114		0.106
295	N	Asparagine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	56	-80.6	146.6	96.84			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														3 interactions	N295-D322; PAE: 1.5	4 interactions	N295-D322; PAE: 1.5										0.906		0.482		0.908		0.855		0.873
296	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	22	-86.3	118.8	96.5			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														2 interactions	V296-I275; PAE: 1.5	5 interactions	V296-I275; PAE: 1.5									2 mutation(s) (Val296Gln: -0.008, Val296Phe: -0.001)	0.271		0.181		0.232	1 mutation(s) (Val296Glu: -0.010)	0.194		0.190
297	I	Isoleucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	100	-93.0	-25.5	95.29			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														3 interactions	I297-E320; PAE: 1.0	3 interactions	I297-D322; PAE: 1.5										0.820		0.505		0.768		0.714		0.707
298	R	Arginine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	122	-145.5	131.5	94.92			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5														3 interactions	R298-E320; PAE: 1.0	3 interactions	R298-E320; PAE: 1.0				R298-E320; PAE: 1.0					1 mutation(s) (Arg298Pro: 0.004)	0.626		0.486		0.597		0.549		0.539
299	I	Isoleucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	52	-113.6	126.6	95.6			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5																2 interactions											0.882		0.727		0.783		0.759		0.776
300	I	Isoleucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	31	-127.0	89.0	95.54			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														3 interactions	I300-L318; PAE: 1.0	4 interactions	I300-L318; PAE: 1.0										0.649		0.542		0.555		0.513		0.515
301	P	Proline	Special, No backbone hydrogen	Beta strand	B (undefined)	E (parallel sheets)	55	-63.1	151.2	96.11			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							115	1.6																											0.950		0.930		0.914		0.884		0.924
302	H	Histidine	Positively-charged		C (loop/coil)	C (loop/coil)	14	-58.5	141.3	96.98			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2														2 interactions	H302-I316; PAE: 1.0	1 interaction											0.448		0.358		0.332		0.287		0.277
303	H	Histidine	Positively-charged	Turn	C (loop/coil)	T (turn)	137	-60.0	-29.0	95.71			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2																											1.004		0.921		0.885		0.853		0.883
304	N	Asparagine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	85	-85.7	-0.5	96.27			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5																3 interactions	N304-H314; PAE: 1.5										0.961		0.919		0.899		0.863		0.853
305	Y	Tyrosine	Aromatic	Turn	C (loop/coil)	C (loop/coil)	39	-74.3	125.7	95.78			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1							Mutation: Y -> F. Strongly increases enzyme activity with a synthetic peptide substrate; when associated with T-311; A-365 and T-391.																181	-1.3														3 interactions	Y305-K311; PAE: 1.5	3 interactions	Y305-A266; PAE: 1.5										0.435		0.282		0.292		0.270		0.271
306	N	Asparagine	Polar/Neutral	Turn	B (undefined)	B (beta bridge)	75	-144.8	99.6	94.24			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														3 interactions	N306-N310; PAE: 1.5	3 interactions	N306-N310; PAE: 1.5										0.866		0.739		0.712		0.661		0.673
307	A	Alanine	Aliphatic	Beta strand	C (loop/coil)	T (turn)	58	-60.9	-26.4	90.95			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8																2 interactions	A307-K311; PAE: 2.0										1.010		0.949		0.936		0.899		0.951
308	A	Alanine	Aliphatic	Beta strand	C (loop/coil)	T (turn)	100	-73.9	-28.2	91.45			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8																											1.014		0.985		0.968		0.950		0.973
309	I	Isoleucine	Aliphatic	Beta strand	C (loop/coil)	T (turn)	137	-86.7	-52.0	89.64			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5																											1.022		0.972		0.947		0.914		0.938
310	N	Asparagine	Polar/Neutral	Beta strand	B (undefined)	B (beta bridge)	42	-158.0	116.7	90.39			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375	3 interactions	N310-N306; PAE: 1.5	3 interactions	N310-N306; PAE: 1.5										0.880		0.751		0.724		0.666		0.685
311	K	Lysine	Positively-charged	Turn	C (loop/coil)	T (turn)	100	-59.2	-23.8	89.54			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1							Mutation: K -> T. Strongly increases enzyme activity with a synthetic peptide substrate; when associated with F-305; A-365 and T-391.																147	-3.9														3 interactions	K311-Y305; PAE: 1.5	3 interactions	K311-A307; PAE: 2.0										0.920		0.767		0.740		0.717		0.722
312	Y	Tyrosine	Aromatic	Turn	C (loop/coil)	T (turn)	78	-112.1	-11.5	91.58			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1							Mutation: Y -> A. Strongly decreases enzyme activity with a synthetic peptide substrate.																181	-1.3												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375			4 interactions	Y312-W431; PAE: 2.0										0.901		0.756		0.718		0.677		0.705
313	N	Asparagine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	30	-77.1	130.6	95.26			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5															N313-N393; PAE: 1.5	3 interactions	N313-N393; PAE: 1.5										0.972		0.951		0.934		0.893		0.924
314	H	Histidine	Positively-charged	Turn	C (loop/coil)	T (turn)	40	57.0	34.6	96.7			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2														1 interaction	H314-Y450; PAE: 1.0	5 interactions	H314-N393, H314-N304; PAE: 1.0, 1.5										0.639		0.490		0.459		0.423		0.415
315	D	Aspartic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	0	-74.2	74.7	96.41	Charge relay system		Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														6 interactions	D315-T445, D315-H267, D315-A266, D315-S430; PAE: 1.0, 1.0, 1.0, 2.0	7 interactions	D315-T445, D315-S430; PAE: 1.0, 2.0										0.226		0.165		0.154		0.138		0.138
316	I	Isoleucine	Aliphatic		C (loop/coil)	C (loop/coil)	0	-149.7	136.6	97.7			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														2 interactions	I316-H302; PAE: 1.0	6 interactions	I316-A266; PAE: 1.0										0.228		0.195		0.174	1 mutation(s) (Ile316Glu: -0.007)	0.165		0.176
317	A	Alanine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-138.5	153.4	97.4			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8														3 interactions	A317-T264; PAE: 1.0	5 interactions	A317-T264, A317-A266; PAE: 1.0, 1.0									1 mutation(s) (Ala317His: 0.005)	0.279	1 mutation(s) (Ala317His: -0.006)	0.232	2 mutation(s) (Ala317Asp: -0.010, Ala317Phe: -0.006)	0.209		0.188		0.184
318	L	Leucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-108.9	139.2	97.85			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														3 interactions	L318-I300; PAE: 1.0	7 interactions	L318-I300; PAE: 1.0										0.244		0.192		0.176		0.164		0.168
319	L	Leucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-115.0	126.2	97.31			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														3 interactions	L319-I262; PAE: 1.0	7 interactions	L319-I262; PAE: 1.0									2 mutation(s) (Leu319Lys: -0.041, Leu319Asn: -0.024)	0.395	1 mutation(s) (Leu319Asn: 0.000)	0.338	2 mutation(s) (Leu319Pro: -0.005, Leu319Lys: -0.004)	0.306	1 mutation(s) (Leu319Pro: -0.006)	0.297	2 mutation(s) (Leu319Pro: -0.014, Leu319Arg: -0.004)	0.306
320	E	Glutamic Acid	Negatively-charged	Beta strand	B (undefined)	E (parallel sheets)	21	-93.5	127.5	97.31			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														5 interactions	E320-I297, E320-R298, E320-K260; PAE: 1.0, 1.0, 1.0	7 interactions	E320-W261, E320-R298; PAE: 1.0, 1.0				E320-R298, E320-K260; PAE: 1.0, 1.0					2 mutation(s) (Glu320Val: -0.011, Glu320Pro: -0.001)	0.332	1 mutation(s) (Glu320Val: -0.010)	0.237		0.247		0.231		0.238
321	L	Leucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-80.1	148.9	98.03			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														3 interactions	L321-K260; PAE: 1.0	7 interactions	L321-K260; PAE: 1.0										0.260	1 mutation(s) (Leu321Asp: -0.013)	0.225		0.194	2 mutation(s) (Leu321Leu: 1.105, Leu321Tyr: -0.006)	0.192		0.202
322	D	Aspartic Acid	Negatively-charged	Beta strand	C (loop/coil)	S (bend)	52	-59.4	-44.5	97.61			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														3 interactions	D322-N295; PAE: 1.5	5 interactions	D322-N295, D322-I297; PAE: 1.5, 1.5										0.578		0.278		0.447		0.432		0.439
323	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	S (bend)	115	-128.6	147.0	98.12			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														3 interactions		1 interaction											1.007		0.864		0.900		0.881		0.938
324	P	Proline	Special, No backbone hydrogen		C (loop/coil)	C (loop/coil)	77	-63.7	147.5	98.0			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							115	1.6														2 interactions	P324-R294; PAE: 1.0	2 interactions											0.748		0.601		0.555		0.533		0.558
325	L	Leucine	Aliphatic		C (loop/coil)	C (loop/coil)	6	-71.7	142.4	97.96			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														3 interactions	L325-E259; PAE: 1.0	4 interactions	L325-E259; PAE: 1.0									3 mutation(s) (Leu325Ter: -0.062, Leu325Gly: -0.017, Leu325Lys: 0.001)	0.247	2 mutation(s) (Leu325Lys: -0.008, Leu325Arg: -0.000)	0.228	2 mutation(s) (Leu325Gly: -0.012, Leu325Pro: -0.003)	0.202	3 mutation(s) (Leu325Asn: -0.014, Leu325Gly: -0.010, Leu325Thr: -0.008)	0.187	1 mutation(s) (Leu325Thr: -0.007)	0.190
326	V	Valine	Aliphatic		C (loop/coil)	C (loop/coil)	97	-88.7	107.3	97.71			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V326-Q292; PAE: 1.0												1.008		0.949		0.903		0.895		0.929
327	L	Leucine	Aliphatic		C (loop/coil)	C (loop/coil)	37	-66.9	135.6	96.9			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107			1 interaction							1 interaction				0.686		0.584		0.552		0.549		0.575
328	N	Asparagine	Polar/Neutral	Beta strand	B (undefined)	B (beta bridge)	42	-157.9	-173.2	95.63			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														2 interactions	N328-T332; PAE: 1.0	3 interactions	N328-T332; PAE: 1.0						1 interaction			3 mutation(s) (Asn328Val: -0.012, Asn328Pro: -0.011, Asn328Leu: -0.007)	0.382	1 mutation(s) (Asn328Leu: -0.010)	0.304		0.291	1 mutation(s) (Asn328Pro: -0.004)	0.282		0.296
329	S	Serine	Polar/Neutral	Beta strand	C (loop/coil)	T (turn)	37	-61.3	-18.0	94.77			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8																	S329-F176; PAE: 1.5					3 interactions	4 interactions				0.985		0.922		0.883	1 mutation(s) (Ser329Glu: 1.117)	0.865		0.901
330	Y	Tyrosine	Aromatic	Beta strand	C (loop/coil)	T (turn)	82	-107.3	-12.5	96.34			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							181	-1.3																3 interactions							1 interaction				0.859		0.679		0.598		0.581		0.605
331	V	Valine	Aliphatic	Beta strand	B (undefined)	B (beta bridge)	0	-135.9	97.2	97.57			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2																4 interactions	V331-P239; PAE: 1.0									1 mutation(s) (Val331His: -0.023)	0.326	2 mutation(s) (Val331Met: -0.005, Val331Glu: 0.001)	0.262		0.240		0.224		0.248
332	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	0	-141.3	139.1	96.65			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														3 interactions	T332-N328, T332-P239; PAE: 1.0, 1.0	5 interactions	T332-N328, T332-P239; PAE: 1.0, 1.0						1 interaction				0.837		0.706		0.654		0.623		0.658
333	P	Proline	Special, No backbone hydrogen		H (helix)	P (polyproline helix)	13	-65.3	154.6	97.66			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							115	1.6												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107		P333-G179; PAE: 1.0	2 interactions						3 interactions	4 interactions				0.386		0.287		0.258		0.243		0.258
334	I	Isoleucine	Aliphatic		H (helix)	P (polyproline helix)	2	-85.8	143.0	97.78			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	3 interactions	I334-I256; PAE: 1.0	5 interactions	I334-I256, I334-L425, I334-W240; PAE: 1.0, 1.0, 1.0									2 mutation(s) (Ile334Lys: -0.024, Ile334Gly: -0.007)	0.237	2 mutation(s) (Ile334Asp: -0.008, Ile334Arg: -0.005)	0.189	1 mutation(s) (Ile334Asn: -0.003)	0.177	2 mutation(s) (Ile334Phe: -0.025, Ile334Trp: -0.003)	0.166	1 mutation(s) (Ile334Asn: -0.004)	0.187
335	C	Cysteine	Special, a very reactive sulfhydryl group		B (undefined)	B (beta bridge)	1	-73.1	140.5	96.87			Coagulation factor IX; Coagulation factor IXa heavy chain				Disulfide bond 178-335		Peptidase S1																							121	2.5														3 interactions	C335-L425, C335-S423; PAE: 1.0, 1.0	6 interactions	C335-G179, C335-L425, C335-C178; PAE: 1.5, 1.0, 1.5						4 interactions			1 mutation(s) (Cys335Leu: -0.045)	0.169		0.101	1 mutation(s) (Cys335Ile: -0.004)	0.083	3 mutation(s) (Cys335Phe: -0.014, Cys335Leu: -0.009, Cys335Ala: -0.006)	0.083	1 mutation(s) (Cys335Trp: -0.002)	0.096
336	I	Isoleucine	Aliphatic		C (loop/coil)	C (loop/coil)	11	-116.6	102.1	96.07			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	1 interaction		2 interactions											0.329	2 mutation(s) (Ile336Asp: -0.017, Ile336Gly: -0.007)	0.270	1 mutation(s) (Ile336Glu: -0.011)	0.250		0.239		0.264
337	A	Alanine	Aliphatic		C (loop/coil)	C (loop/coil)	2	-69.4	169.4	93.76			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107			6 interactions	A337-T342; PAE: 1.5										0.331	1 mutation(s) (Ala337Tyr: 0.001)	0.210		0.178		0.161	1 mutation(s) (Ala337Tyr: -0.008)	0.162
338	D	Aspartic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	44	-65.2	164.8	92.66			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	3 interactions	D338-T342; PAE: 1.0	4 interactions	D338-T342; PAE: 1.0										0.846		0.759		0.670		0.625		0.654
339	K	Lysine	Positively-charged	Helix	H (helix)	H (α-helix)	103	-54.3	-35.1	92.94			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9														2 interactions	K339-N343; PAE: 1.0	4 interactions	K339-N343; PAE: 1.0									1 mutation(s) (Lys339Glu: 1.347)	1.091		1.005		1.001	3 mutation(s) (Lys339Ala: 1.100, Lys339Glu: 1.107, Lys339Lys: 1.113)	0.963		0.984
340	E	Glutamic Acid	Negatively-charged	Helix	H (helix)	H (α-helix)	130	-72.5	-53.6	90.95			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														2 interactions	E340-I344; PAE: 1.0	3 interactions	E340-I344; PAE: 1.0										1.027	1 mutation(s) (Glu340Ile: 1.191)	1.018		0.983		0.921		0.954
341	Y	Tyrosine	Aromatic	Helix	H (helix)	H (α-helix)	8	-65.2	-39.8	91.26			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							181	-1.3														3 interactions	Y341-F345, Y341-C145; PAE: 1.0, 4.0	4 interactions	Y341-F345, Y341-F144; PAE: 1.0, 2.5					4 interactions	1 interaction				1.072	1 mutation(s) (Tyr341Phe: 1.177)	0.934		0.832		0.750		0.722
342	T	Threonine	Polar/Neutral	Helix	H (helix)	H (α-helix)	3	-57.9	-33.7	92.34			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														3 interactions	T342-L346, T342-D338; PAE: 1.0, 1.0	9 interactions	T342-S448, T342-A337, T342-L346, T342-D338; PAE: 1.0, 1.5, 1.0, 1.0										0.612	1 mutation(s) (Thr342Lys: -0.000)	0.401		0.348	1 mutation(s) (Thr342Arg: -0.006)	0.322		0.301
343	N	Asparagine	Polar/Neutral	Helix	H (helix)	H (α-helix)	33	-74.1	-34.8	92.17			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														3 interactions	N343-K339, N343-S448, N343-K446; PAE: 1.0, 1.5, 1.5	4 interactions	N343-K347, N343-K339, N343-S448; PAE: 1.0, 1.0, 1.5										0.854		0.739		0.702	2 mutation(s) (Asn343Asp: 1.107, Asn343Glu: 1.120)	0.651		0.705
344	I	Isoleucine	Aliphatic	Helix	H (helix)	H (α-helix)	67	-68.3	-50.5	89.37			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														2 interactions	I344-E340; PAE: 1.0	4 interactions	I344-F348, I344-E340; PAE: 1.5, 1.0										1.021		0.973		0.959		0.944		0.953
345	F	Phenylalanine	Aromatic	Helix	H (helix)	H (α-helix)	3	-59.3	-42.5	89.33			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8														3 interactions	F345-Y341; PAE: 1.0	6 interactions	F345-Y341, F345-T417; PAE: 1.0, 2.0										0.554		0.418		0.362		0.340		0.331
346	L	Leucine	Aliphatic	Helix	H (helix)	H (α-helix)	9	-55.6	-32.3	90.12			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														2 interactions	L346-T342; PAE: 1.0	3 interactions	L346-T342; PAE: 1.0										0.870		0.641		0.566		0.513		0.543
347	K	Lysine	Positively-charged	Helix	C (loop/coil)	T (turn)	156	-81.5	-4.0	88.07			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9														3 interactions		3 interactions	K347-N343; PAE: 1.0										0.951		0.822		0.798		0.749		0.776
348	F	Phenylalanine	Aromatic		C (loop/coil)	T (turn)	121	-64.6	-5.8	81.84			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8																3 interactions	F348-I344; PAE: 1.5										1.037		0.965		0.960	1 mutation(s) (Phe348Met: 1.101)	0.946		0.953
349	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	S (bend)	29	103.8	-18.0	76.87			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														3 interactions	G349-L376; PAE: 2.5	4 interactions	G349-L376; PAE: 2.5										0.895		0.767		0.675		0.625		0.643
350	S	Serine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	24	-151.4	155.8	91.0			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8														1 interaction		4 interactions	S350-R373; PAE: 2.0										1.084		1.016		1.013		0.998		1.013
351	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	B (undefined)	E (parallel sheets)	1	-139.0	172.5	92.91			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														3 interactions	G351-V374; PAE: 1.5	6 interactions	G351-H415, G351-V374; PAE: 1.0, 1.5										0.494		0.325		0.286		0.273		0.258
352	Y	Tyrosine	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	68	-102.9	136.1	93.84			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							181	-1.3														3 interactions	Y352-V416; PAE: 1.0	6 interactions	Y352-V416; PAE: 1.0										0.859		0.723		0.710		0.654		0.706
353	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	5	-116.2	141.6	93.05			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V353-L372; PAE: 1.0	6 interactions	V353-L372; PAE: 1.0										0.827		0.599		0.511		0.462		0.470
354	S	Serine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	2	-138.5	150.0	92.58			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8														3 interactions	S354-Q241; PAE: 1.5	5 interactions	S354-Q241; PAE: 1.5										1.010		0.878		0.847		0.819		0.861
355	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	B (undefined)	E (parallel sheets)	2	169.6	178.8	90.92			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														3 interactions	G355-Q370; PAE: 1.0	5 interactions	G355-Q370; PAE: 1.0										0.992		0.885		0.855		0.821		0.882
356	W	Tryptophan	Aromatic	Beta strand	C (loop/coil)	C (loop/coil)	6	-109.2	24.5	87.79			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							204	-0.9														3 interactions	W356-H282; PAE: 1.5	8 interactions	W356-L369, W356-A366; PAE: 1.0, 2.0										0.925		0.690		0.633		0.600		0.621
357	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	C (loop/coil)	C (loop/coil)	3	-61.1	176.2	74.08			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														4 interactions	G357-D410, G357-A366; PAE: 3.0, 4.0	7 interactions	G357-D410, G357-A366; PAE: 3.0, 4.0										1.105		1.013		1.001		0.991		1.028
358	R	Arginine	Positively-charged	Beta strand	B (undefined)	B (beta bridge)	97	-63.5	132.5	62.09			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5														5 interactions	R358-Q408; PAE: 7.5	6 interactions											1.070		0.988		0.921		0.889		0.943
359	V	Valine	Aliphatic	Beta strand	C (loop/coil)	S (bend)	21	-62.2	-31.2	54.18			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V359-V228, V359-R364; PAE: 10.5, 6.5	5 interactions											1.044		1.002		1.008		0.994		1.022
360	F	Phenylalanine	Aromatic	Beta strand	C (loop/coil)	S (bend)	111	-147.6	164.2	52.46			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8																2 interactions											1.105		1.032		1.046	1 mutation(s) (Phe360Glu: 1.113)	1.049		1.066
361	H	Histidine	Positively-charged		C (loop/coil)	T (turn)	83	-56.6	123.7	54.29			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2														1 interaction		3 interactions											1.003		0.973		0.984		0.959		0.991
362	K	Lysine	Positively-charged		C (loop/coil)	T (turn)	165	60.6	15.7	59.06			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9																1 interaction											1.022		0.904		0.844		0.829		0.842
363	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	C (loop/coil)	12	-80.8	-177.5	60.36			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														1 interaction		1 interaction											0.990		0.940		0.894		0.850		0.903
364	R	Arginine	Positively-charged		H (helix)	P (polyproline helix)	214	-72.0	147.9	69.35			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5														3 interactions	R364-V359; PAE: 6.5	3 interactions											1.051		0.988		0.957	1 mutation(s) (Arg364Asn: 1.102)	0.934		0.961
365	S	Serine	Polar/Neutral		B (undefined)	B (beta bridge)	67	-65.9	147.9	72.79			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8																2 interactions											1.011		0.995		0.978		0.968		0.993
366	A	Alanine	Aliphatic		H (helix)	P (polyproline helix)	2	-70.6	133.8	78.71			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8							dbSNP: rs1928115979; Variant type: LP/P; AA change: Ala366Asp; PTM type: Phosphorylation; PTM morphology: A*LVLQyLRVPL; Var class: II							3 interactions	A366-G357; PAE: 4.0	6 interactions	A366-W356, A366-G357; PAE: 2.0, 4.0										1.062		0.993		0.963		0.947		0.980
367	L	Leucine	Aliphatic		C (loop/coil)	S (bend)	64	-75.7	-41.6	86.04			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														3 interactions	L367-I284; PAE: 2.0	4 interactions											1.082		1.023		1.023		1.005		1.027
368	V	Valine	Aliphatic		B (undefined)	B (beta bridge)	18	-96.1	140.1	89.74			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2																3 interactions											1.071		0.950		0.912		0.863		0.907
369	L	Leucine	Aliphatic		H (helix)	P (polyproline helix)	6	-52.2	125.5	91.32			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														4 interactions	L369-H282, L369-A233; PAE: 1.0, 1.0	7 interactions	L369-H282, L369-W356; PAE: 1.0, 1.0										1.040		0.946		0.931		0.905		0.925
370	Q	Glutamine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	4	-102.2	156.0	89.3			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														3 interactions	Q370-G355, Q370-D232; PAE: 1.0, 1.0	9 interactions	Q370-G355, Q370-D232, Q370-R226; PAE: 1.0, 1.0, 12.0										0.846		0.672		0.624		0.586		0.599
371	Y	Tyrosine	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	38	-140.7	154.9	90.76			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							181	-1.3														3 interactions	Y371-E231; PAE: 1.5	6 interactions	Y371-E231; PAE: 1.5										1.087		0.978		0.952		0.936		0.975
372	L	Leucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	12	-142.6	137.1	88.72			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														3 interactions	L372-V353; PAE: 1.0	8 interactions	L372-D405, L372-V353; PAE: 5.0, 1.0										1.042		0.982		0.980	1 mutation(s) (Leu372Trp: 1.103)	0.952		1.008
373	R	Arginine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	133	-86.3	118.3	90.61			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5														1 interaction		5 interactions	R373-S350; PAE: 2.0										0.995		0.868		0.819		0.772		0.823
374	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-115.9	133.2	91.21			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V374-G351; PAE: 1.5	3 interactions	V374-G351; PAE: 1.5										0.739		0.491		0.426		0.397		0.401
375	P	Proline	Special, No backbone hydrogen	Beta strand	B (undefined)	E (parallel sheets)	35	-79.5	147.0	92.94			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							115	1.6														3 interactions	P375-G398; PAE: 1.5	6 interactions	P375-G398; PAE: 1.5										1.067		0.971		0.967		0.949		0.992
376	L	Leucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	56	-67.6	132.5	94.32			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														3 interactions	L376-G349; PAE: 2.5	4 interactions	L376-G349; PAE: 2.5										0.900		0.722		0.647		0.586		0.611
377	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	17	-99.3	135.3	93.25			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V377-C396; PAE: 1.0	2 interactions	V377-G398; PAE: 1.0										0.758		0.546		0.473		0.426		0.433
378	D	Aspartic Acid	Negatively-charged		H (helix)	P (polyproline helix)	89	-62.1	151.9	93.69			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														2 interactions	D378-C382; PAE: 1.0	3 interactions	D378-C382; PAE: 1.0										0.858		0.734		0.689		0.643		0.723
379	R	Arginine	Positively-charged	Helix	H (helix)	H (α-helix)	102	-62.8	-34.1	92.81			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5							dbSNP: rs137852258; Variant type: LP/P; AA change: Arg379Gly; PTM type: Phosphorylation; PTM morphology: LVDR*AtCLRST; Var class: II&rs137852259							5 interactions	R379-Y391, R379-I390, R379-L383; PAE: 2.0, 2.0, 1.0	3 interactions	R379-L383; PAE: 1.0									1 mutation(s) (Arg379Glu: 1.342)	1.205		0.981		0.956		0.972		0.977
380	A	Alanine	Aliphatic	Helix	H (helix)	H (α-helix)	54	-71.2	-42.1	95.59			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8														3 interactions	A380-R384; PAE: 1.0	3 interactions	A380-R384; PAE: 1.0										1.024		0.988		0.983		0.942		0.976
381	T	Threonine	Polar/Neutral	Helix	H (helix)	H (α-helix)	37	-64.8	-43.8	94.46			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7															T381-S385; PAE: 1.0	3 interactions	T381-S385; PAE: 1.0										1.096		0.954		0.919		0.893		0.935
382	C	Cysteine	Special, a very reactive sulfhydryl group	Helix	H (helix)	H (α-helix)	2	-58.3	-43.7	93.22			Coagulation factor IX; Coagulation factor IXa heavy chain				Disulfide bond 382-396		Peptidase S1																							121	2.5							dbSNP: rs1303221289; Variant type: LP/P; AA change: Cys382Tyr; PTM type: Phosphorylation; PTM morphology: LVDRAtC*LRST; Var class: II							2 interactions	C382-D378; PAE: 1.0	5 interactions	C382-C396, C382-D378; PAE: 1.5, 1.0		C382-C396; PAE: 1.5								0.495		0.256		0.201		0.184		0.146
383	L	Leucine	Aliphatic	Helix	H (helix)	H (α-helix)	79	-69.3	-32.0	94.71			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8							dbSNP: -; Variant type: LP/P; AA change: Leu383Ile; PTM type: Phosphorylation; PTM morphology: LVDRAtCL*RST; Var class: II&rs1677128088							3 interactions	L383-R379; PAE: 1.0	4 interactions	L383-R379; PAE: 1.0					1 interaction	2 interactions				1.103		0.996		0.994	4 mutation(s) (Leu383Thr: 1.104, Leu383Ala: 1.117, Leu383Ser: 1.124, Leu383Gln: 1.125)	0.977		0.988
384	R	Arginine	Positively-charged	Helix	H (helix)	H (α-helix)	189	-78.1	-25.4	94.23			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5							dbSNP: rs137852283; Variant type: LP/P; AA change: Arg384Leu; PTM type: Phosphorylation; PTM morphology: LVDRAtCLR*ST; Var class: II							3 interactions	R384-A380; PAE: 1.0	3 interactions	R384-A380; PAE: 1.0					3 interactions	4 interactions				1.099		0.946	1 mutation(s) (Arg384Asn: 1.152)	0.910	1 mutation(s) (Arg384Asn: 1.142)	0.889		0.889
385	S	Serine	Polar/Neutral		C (loop/coil)	S (bend)	24	-72.1	-19.0	90.05			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8														2 interactions	S385-T381, S385-K440; PAE: 1.0, 2.0	5 interactions	S385-T381, S385-K440; PAE: 1.0, 2.0						1 interaction				1.095		1.015		0.993	1 mutation(s) (Ser385Tyr: 1.109)	0.981		1.002
386	T	Threonine	Polar/Neutral	Beta strand	C (loop/coil)	C (loop/coil)	17	-130.6	155.4	89.51			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														2 interactions	T386-E433; PAE: 3.5	1 interaction							2 interactions				1.093		0.966		0.918		0.877		0.927
387	K	Lysine	Positively-charged	Beta strand	C (loop/coil)	S (bend)	205	-88.1	-15.4	89.56			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375									1 interaction	4 interactions		1 interaction		1.053		0.933	1 mutation(s) (Lys387Asn: 1.154)	0.867	1 mutation(s) (Lys387Asn: 1.142)	0.840		0.871
388	F	Phenylalanine	Aromatic	Beta strand	C (loop/coil)	S (bend)	128	-78.0	152.4	89.5			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375										1 interaction				1.108		1.007		0.972	1 mutation(s) (Phe388Ile: 1.101)	0.945		0.977
389	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	94	-75.8	120.6	91.89			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375									1 interaction	2 interactions				1.071		1.002		0.997	1 mutation(s) (Thr389Pro: 1.117)	0.977		0.996
390	I	Isoleucine	Aliphatic		C (loop/coil)	C (loop/coil)	6	-100.4	111.7	92.7			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														3 interactions	I390-R379; PAE: 2.0	1 interaction											1.032		0.939		0.917	1 mutation(s) (Ile390Ile: 1.104)	0.874		0.897
391	Y	Tyrosine	Aromatic	Turn	C (loop/coil)	C (loop/coil)	77	-77.3	171.1	94.62			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1							Mutation: Y -> T. Strongly increases enzyme activity with a synthetic peptide substrate; when associated with F-305; T-311 and A-365.																181	-1.3														1 interaction	Y391-R379; PAE: 2.0	1 interaction						1 interaction					1.087		1.027		1.024	1 mutation(s) (Tyr391Pro: 1.100)	0.990		1.034
392	N	Asparagine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	101	-75.1	-9.9	94.4			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														2 interactions																					
393	N	Asparagine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	14	-95.9	11.1	95.49			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														3 interactions	N393-N313, N393-Y450, N393-K446; PAE: 1.5, 1.5, 1.0	7 interactions	N393-N313, N393-H314, N393-K446; PAE: 1.5, 1.0, 1.0										0.851		0.671		0.619		0.561		0.586
394	M	Methionine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	5	-121.9	156.9	96.15			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							149	1.9												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375			2 interactions											0.886		0.710		0.666		0.612		0.637
395	F	Phenylalanine	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	15	-141.1	160.4	95.32			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8														3 interactions	F395-Y444; PAE: 1.0	6 interactions	F395-Y444; PAE: 1.0										0.275		0.118		0.102		0.097		0.092
396	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	B (undefined)	E (parallel sheets)	1	-103.5	143.8	93.62			Coagulation factor IX; Coagulation factor IXa heavy chain				Disulfide bond 382-396		Peptidase S1																							121	2.5														3 interactions	C396-V377; PAE: 1.0	4 interactions	C396-C382; PAE: 1.5		C396-C382; PAE: 1.5								0.294		0.137		0.104		0.101	1 mutation(s) (Cys396Gln: -0.016)	0.079
397	A	Alanine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-142.1	146.8	92.51			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8														3 interactions	A397-G442; PAE: 1.0	6 interactions	A397-G442; PAE: 1.0										0.487		0.307		0.251		0.239		0.247
398	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	C (loop/coil)	S (bend)	3	141.4	-178.8	89.84			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														3 interactions	G398-P375; PAE: 1.5	4 interactions	G398-V377, G398-P375; PAE: 1.0, 1.5										0.876		0.577		0.503		0.468		0.469
399	F	Phenylalanine	Aromatic		C (loop/coil)	C (loop/coil)	47	-100.7	133.5	86.8			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8																5 interactions	F399-R404; PAE: 5.0										1.003		0.986		0.970		0.944		0.993
400	H	Histidine	Positively-charged	Beta strand	C (loop/coil)	T (turn)	117	-60.2	-37.1	85.18			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2															H400-Y441, H400-G439; PAE: 1.5, 2.0	4 interactions	H400-Y441, H400-G439; PAE: 1.5, 2.0										1.076		1.032		1.038		0.996		1.052
401	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	T (turn)	155	-64.8	-13.6	82.07			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														2 interactions		2 interactions											0.994		0.954		0.949		0.932		0.991
402	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	C (loop/coil)	C (loop/coil)	6	68.7	-147.2	73.57			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4																1 interaction											1.072		1.038		1.027	2 mutation(s) (Gly402Glu: 1.103, Gly402Trp: 1.124)	1.012		1.037
403	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	C (loop/coil)	S (bend)	37	68.7	-9.8	62.13			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														2 interactions	G403-A436; PAE: 5.5	3 interactions											1.074		1.028		1.031	3 mutation(s) (Gly403Asp: 1.102, Gly403Thr: 1.122, Gly403Ser: 1.134)	1.033		1.031
404	R	Arginine	Positively-charged		C (loop/coil)	C (loop/coil)	99	-148.5	121.6	62.18			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5																6 interactions	R404-F399; PAE: 5.0										0.957		0.920	1 mutation(s) (Arg404His: 1.143)	0.928	8 mutation(s) (Arg404Gly: 1.106, Arg404Ser: 1.114, Arg404Trp: 1.116, Arg404Leu: 1.117, Arg404Pro: 1.117, Arg404Tyr: 1.119, Arg404Arg: 1.127, Arg404His: 1.138)	0.913		0.929
405	D	Aspartic Acid	Negatively-charged		C (loop/coil)	C (loop/coil)	5	-163.3	157.2	60.03			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														4 interactions	D405-A436; PAE: 5.0	7 interactions	D405-G442, D405-L372, D405-A436; PAE: 6.5, 5.0, 5.0										1.094		1.014		1.023	1 mutation(s) (Asp405Glu: 1.104)	1.003		1.041
406	S	Serine	Polar/Neutral		C (loop/coil)	C (loop/coil)	15	-67.6	141.3	60.89			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8														2 interactions	S406-Y444; PAE: 7.5	3 interactions											1.075		1.038		1.037	1 mutation(s) (Ser406Glu: 1.118)	1.022		1.047
407	C	Cysteine	Special, a very reactive sulfhydryl group		C (loop/coil)	C (loop/coil)	10	-123.8	-179.1	61.02			Coagulation factor IX; Coagulation factor IXa heavy chain				Disulfide bond 407-435		Peptidase S1																							121	2.5																3 interactions		1 interaction	C407-C435; PAE: 10.0								0.897		0.734		0.658		0.589		0.651
408	Q	Glutamine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	109	-58.5	124.0	54.99			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5												Pocket 1: Mean pLDDT: 80.6, Volume: 382.38 Å³, Druggability score: 0.34	0.3429	3 interactions	Q408-R358; PAE: 7.5	2 interactions											1.052		1.027		1.032	1 mutation(s) (Gln408Thr: 1.106)	1.002		1.039
409	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Turn	C (loop/coil)	T (turn)	11	107.9	-16.0	58.25			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4																5 interactions											1.099		0.973		0.968		0.942		0.978
410	D	Aspartic Acid	Negatively-charged	Turn	C (loop/coil)	C (loop/coil)	12	-81.4	-10.3	76.62			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														4 interactions	D410-G357; PAE: 3.0	7 interactions	D410-G357; PAE: 3.0										1.030		0.954		0.974		0.971		0.984
411	S	Serine	Polar/Neutral	Turn	C (loop/coil)	T (turn)	7	-48.8	132.6	85.31	Charge relay system		Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8														5 interactions	S411-S430, S411-G253; PAE: 2.5, 2.0	5 interactions											1.116		1.032		1.055	4 mutation(s) (Ser411Val: 1.109, Ser411Asp: 1.109, Ser411Ile: 1.110, Ser411Trp: 1.113)	1.054		1.055
412	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Turn	C (loop/coil)	T (turn)	0	82.5	-13.0	89.96			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														4 interactions	G412-I429; PAE: 1.0	9 interactions	G412-A265; PAE: 1.5										0.950		0.848		0.775	1 mutation(s) (Gly412Ile: 1.116)	0.763		0.742
413	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	C (loop/coil)	0	-66.1	165.2	93.93			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														2 interactions	G413-I429; PAE: 1.0	7 interactions	G413-G253, G413-I429; PAE: 1.0, 1.0										1.028		0.862		0.797		0.769		0.790
414	P	Proline	Special, No backbone hydrogen	Beta strand	B (undefined)	E (parallel sheets)	0	-77.7	147.6	96.53			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							115	1.6																7 interactions											1.000		0.825		0.798	3 mutation(s) (Pro414Gln: 1.104, Pro414Leu: 1.109, Pro414Ile: 1.118)	0.808		0.765
415	H	Histidine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	2	-107.9	117.2	96.02			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							155	-3.2														4 interactions	H415-G427, H415-T426; PAE: 1.0, 1.0	8 interactions	H415-G427, H415-T426, H415-G351; PAE: 1.0, 1.0, 1.0									1 mutation(s) (His415Gln: -0.007)	0.463	1 mutation(s) (His415Pro: -0.010)	0.293		0.249		0.234	3 mutation(s) (His415Thr: -0.008, His415Arg: -0.008, His415Pro: -0.007)	0.221
416	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	1	-111.0	136.9	96.56			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V416-Y352; PAE: 1.0	6 interactions	V416-S423, V416-Y352; PAE: 1.0, 1.0									1 mutation(s) (Val416Asp: 0.004)	0.806	1 mutation(s) (Val416Lys: 0.001)	0.673		0.647	2 mutation(s) (Val416Val: 1.103, Val416Pro: -0.005)	0.624		0.660
417	T	Threonine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	3	-113.6	124.3	95.14			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														3 interactions	T417-T426, T417-F424; PAE: 1.0, 1.0	7 interactions	T417-F345, T417-T426, T417-F424; PAE: 2.0, 1.0, 1.0										0.537		0.419		0.364		0.338		0.354
418	E	Glutamic Acid	Negatively-charged	Beta strand	B (undefined)	E (parallel sheets)	101	-83.9	133.2	92.13			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5																4 interactions											1.064		0.984		0.954		0.911		0.993
419	V	Valine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	9	-131.0	112.6	88.77			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2																2 interactions											0.858		0.732		0.664		0.621		0.654
420	E	Glutamic Acid	Negatively-charged		C (loop/coil)	T (turn)	152	48.3	44.2	84.92			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5																							1 interaction				1.026		0.985		0.938		0.916		0.957
421	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	T (turn)	45	79.3	-0.4	88.74			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4																							2 interactions				0.831		0.699		0.610		0.584		0.618
422	T	Threonine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	4	-104.8	126.1	93.16			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7																2 interactions						1 interaction	4 interactions				0.649		0.518		0.442		0.409		0.440
423	S	Serine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	7	-88.3	128.0	95.82			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8															S423-C335, S423-G179; PAE: 1.0, 1.0	6 interactions	S423-V416, S423-G179; PAE: 1.0, 1.0					3 interactions	1 interaction				0.983		0.892		0.866	3 mutation(s) (Ser423Asn: 1.107, Ser423Tyr: 1.113, Ser423Trp: 1.138)	0.850		0.890
424	F	Phenylalanine	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	1	-118.2	137.5	96.53			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							165	2.8														3 interactions	F424-T417; PAE: 1.0	9 interactions	F424-T417; PAE: 1.0										0.220	3 mutation(s) (Phe424Cys: -0.013, Phe424Ile: -0.005, Phe424Lys: -0.003)	0.183	2 mutation(s) (Phe424Arg: -0.012, Phe424Lys: -0.006)	0.165	1 mutation(s) (Phe424Gln: -0.006)	0.163	2 mutation(s) (Phe424Arg: -0.013, Phe424Thr: -0.005)	0.171
425	L	Leucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-74.4	113.0	97.82			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	3.8														3 interactions	L425-C335; PAE: 1.0	7 interactions	L425-C335, L425-I334; PAE: 1.0, 1.0										0.251	3 mutation(s) (Leu425Lys: -0.004, Leu425Cys: -0.001, Leu425Pro: 0.001)	0.165		0.129	3 mutation(s) (Leu425Gly: -0.005, Leu425Pro: -0.005, Leu425Trp: -0.003)	0.123		0.133
426	T	Threonine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	1	-110.8	-23.4	96.95			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														3 interactions	T426-H415, T426-V447, T426-T417; PAE: 1.0, 1.0, 1.0	6 interactions	T426-H415, T426-V447, T426-T417; PAE: 1.0, 1.0, 1.0										0.146	2 mutation(s) (Thr426Cys: -0.012, Thr426Val: 0.001)	0.096	1 mutation(s) (Thr426Pro: -0.003)	0.074	2 mutation(s) (Thr426Gly: -0.012, Thr426Lys: -0.004)	0.073	3 mutation(s) (Thr426Ala: -0.013, Thr426Pro: -0.008, Thr426Gly: -0.008)	0.076
427	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	B (undefined)	E (parallel sheets)	0	-150.1	170.0	96.92			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														3 interactions	G427-H415; PAE: 1.0	6 interactions	G427-H415; PAE: 1.0									3 mutation(s) (Gly427Pro: -0.025, Gly427Arg: -0.005, Gly427Ser: 0.006)	0.106	2 mutation(s) (Gly427Arg: -0.006, Gly427Trp: -0.001)	0.076		0.066	3 mutation(s) (Gly427Tyr: -0.007, Gly427Gln: -0.004, Gly427Ser: -0.004)	0.064	2 mutation(s) (Gly427Lys: -0.003, Gly427Cys: -0.002)	0.070
428	I	Isoleucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	0	-127.8	131.5	97.17			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														3 interactions	I428-T445; PAE: 1.0	7 interactions	I428-T445; PAE: 1.0										0.488	2 mutation(s) (Ile428Asp: -0.022, Ile428Ala: -0.007)	0.371	2 mutation(s) (Ile428Ala: -0.005, Ile428Asp: -0.003)	0.324	1 mutation(s) (Ile428Ala: -0.009)	0.301		0.319
429	I	Isoleucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	6	-62.9	122.1	94.37			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														4 interactions	I429-G413, I429-G412; PAE: 1.0, 1.0	9 interactions	I429-G413; PAE: 1.0										1.095		1.026		1.017	1 mutation(s) (Ile429Lys: 1.106)	1.026		1.047
430	S	Serine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	1	-112.8	-69.8	92.06			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8														5 interactions	S430-D315, S430-I443, S430-S411; PAE: 2.0, 1.0, 2.5	7 interactions	S430-D315, S430-T445; PAE: 2.0, 1.5										0.859		0.741		0.671		0.634		0.653
431	W	Tryptophan	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	31	-154.9	168.7	87.72			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							204	-0.9												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375	3 interactions	W431-I443; PAE: 1.0	5 interactions	W431-I443, W431-Y312; PAE: 1.0, 2.0										0.985		0.979		0.975	1 mutation(s) (Trp431Gln: 1.104)	0.966		1.011
432	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		B (undefined)	E (parallel sheets)	41	-156.0	157.1	78.84			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375			1 interaction											0.972		0.905		0.896		0.876		0.919
433	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	S (bend)	43	-92.9	91.3	71.59			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5												Pocket 4: Mean pLDDT: 86.53, Volume: 398.98 Å³, Druggability score: 0.04	0.0375	3 interactions	E433-T386; PAE: 3.5	3 interactions	E433-K440; PAE: 4.0			1 interaction	E433-K440; PAE: 4.0						1.008		0.928		0.921		0.887		0.955
434	E	Glutamic Acid	Negatively-charged	Beta strand	C (loop/coil)	S (bend)	107	57.8	124.6	69.64			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5																1 interaction											1.111		1.027		1.016	1 mutation(s) (Glu434Asp: 1.112)	0.996		1.017
435	C	Cysteine	Special, a very reactive sulfhydryl group	Beta strand	C (loop/coil)	T (turn)	23	-63.2	130.6	67.08			Coagulation factor IX; Coagulation factor IXa heavy chain				Disulfide bond 407-435		Peptidase S1																							121	2.5														1 interaction		5 interactions		1 interaction	C435-C407; PAE: 10.0								0.713		0.488		0.438		0.380		0.380
436	A	Alanine	Aliphatic	Beta strand	C (loop/coil)	T (turn)	14	62.3	23.2	66.44			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							89	1.8														3 interactions	A436-D405, A436-G403; PAE: 5.0, 5.5	5 interactions	A436-D405; PAE: 5.0										1.057		1.005		0.968		0.956		1.001
437	M	Methionine	Aliphatic		C (loop/coil)	C (loop/coil)	82	-70.7	132.3	74.65			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							149	1.9																1 interaction											1.050		1.016		1.019	1 mutation(s) (Met437Leu: 1.130)	0.991		1.032
438	K	Lysine	Positively-charged		C (loop/coil)	T (turn)	157	-55.9	130.9	82.22			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9														2 interactions		3 interactions											1.017		1.001		0.982	2 mutation(s) (Lys438His: 1.102, Lys438Ser: 1.108)	0.978		0.999
439	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible		C (loop/coil)	T (turn)	20	75.8	4.7	83.41			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4															G439-H400; PAE: 2.0	3 interactions	G439-H400; PAE: 2.0										0.908		0.774		0.731		0.687		0.757
440	K	Lysine	Positively-charged		C (loop/coil)	C (loop/coil)	38	-111.1	159.1	86.4			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9														3 interactions	K440-S385; PAE: 2.0	4 interactions	K440-E433, K440-S385; PAE: 4.0, 2.0			1 interaction	K440-E433; PAE: 4.0						0.979		0.845		0.845	1 mutation(s) (Lys440Asn: 1.108)	0.826		0.847
441	Y	Tyrosine	Aromatic		C (loop/coil)	C (loop/coil)	13	-139.3	154.0	89.91			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							181	-1.3															Y441-H400; PAE: 1.5	3 interactions	Y441-H400; PAE: 1.5										0.821		0.646		0.602		0.558	1 mutation(s) (Tyr441Asp: -0.006)	0.574
442	G	Glycine	Special, lack of a chiral carbon, smallest amino acid, very flexible	Beta strand	B (undefined)	E (parallel sheets)	0	-67.9	141.7	90.12			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							75	-0.4														3 interactions	G442-A397; PAE: 1.0	6 interactions	G442-A397, G442-D405; PAE: 1.0, 6.5										1.050		0.861	1 mutation(s) (Gly442Ter: -0.015)	0.844		0.823		0.845
443	I	Isoleucine	Aliphatic	Beta strand	B (undefined)	E (parallel sheets)	6	-110.3	129.7	93.18			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														4 interactions	I443-S430, I443-W431; PAE: 1.0, 1.0	7 interactions	I443-W431; PAE: 1.0										0.844		0.611		0.553		0.519		0.523
444	Y	Tyrosine	Aromatic	Beta strand	B (undefined)	E (parallel sheets)	0	-122.0	140.8	95.45			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							181	-1.3														4 interactions	Y444-S406, Y444-F395; PAE: 7.5, 1.0	7 interactions	Y444-F395; PAE: 1.0										0.534	1 mutation(s) (Tyr444Arg: -0.003)	0.374		0.325		0.289	2 mutation(s) (Tyr444Arg: -0.009, Tyr444Asp: -0.007)	0.285
445	T	Threonine	Polar/Neutral	Beta strand	B (undefined)	E (parallel sheets)	1	-69.2	124.8	97.0			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														4 interactions	T445-D315, T445-I428; PAE: 1.0, 1.0	8 interactions	T445-S430, T445-D315, T445-I428; PAE: 1.5, 1.0, 1.0									1 mutation(s) (Thr445Lys: -0.021)	0.597	1 mutation(s) (Thr445Lys: -0.012)	0.547		0.480		0.446		0.476
446	K	Lysine	Positively-charged	Beta strand	B (undefined)	E (parallel sheets)	38	-78.6	103.0	96.77			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9														3 interactions	K446-N393, K446-N343; PAE: 1.0, 1.5	5 interactions	K446-N393; PAE: 1.0									1 mutation(s) (Lys446Glu: 1.337)	0.866		0.614		0.560		0.568		0.546
447	V	Valine	Aliphatic	Helix	H (helix)	G (3₁₀-helix)	0	-60.4	-31.6	97.79			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														2 interactions	V447-T426; PAE: 1.0	5 interactions	V447-T426, V447-V451; PAE: 1.0, 1.0										0.418	3 mutation(s) (Val447Asp: -0.014, Val447Glu: -0.002, Val447Lys: -0.002)	0.347	3 mutation(s) (Val447Asp: -0.014, Val447Asn: -0.005, Val447Gln: -0.004)	0.315	2 mutation(s) (Val447Gln: -0.007, Val447Asp: -0.005)	0.292	1 mutation(s) (Val447Asp: -0.013)	0.302
448	S	Serine	Polar/Neutral	Helix	H (helix)	G (3₁₀-helix)	1	-57.2	-19.7	96.42			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							105	-0.8															S448-N343; PAE: 1.5	3 interactions	S448-T342, S448-N343; PAE: 1.0, 1.5										0.675		0.523		0.461		0.409		0.435
449	R	Arginine	Positively-charged	Helix	H (helix)	G (3₁₀-helix)	128	-80.6	-14.0	96.76			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							175	-4.5																1 interaction										3 mutation(s) (Arg449Asp: 1.350, Arg449Cys: 1.365, Arg449Glu: 1.367)	1.236		1.051		1.021	8 mutation(s) (Arg449Val: 1.099, Arg449Met: 1.113, Arg449Glu: 1.141, Arg449Tyr: 1.141, Arg449His: 1.143, Arg449Pro: 1.144, Arg449Asn: 1.150, Arg449Ala: 1.162)	1.069		1.033
450	Y	Tyrosine	Aromatic	Helix	C (loop/coil)	T (turn)	5	-124.4	-3.0	97.82			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							181	-1.3														4 interactions	Y450-N393, Y450-H314, Y450-I454; PAE: 1.5, 1.0, 1.0	4 interactions	Y450-I454; PAE: 1.0										0.219		0.129		0.108		0.103	1 mutation(s) (Tyr450Trp: -0.015)	0.108
451	V	Valine	Aliphatic	Helix	H (helix)	H (α-helix)	1	-45.9	-51.6	96.58			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							117	4.2														3 interactions	V451-K455; PAE: 1.0	8 interactions	V451-K455, V451-V447; PAE: 1.0, 1.0										0.770		0.579		0.511		0.498		0.479
452	N	Asparagine	Polar/Neutral	Helix	H (helix)	H (α-helix)	117	-61.5	-40.5	95.63			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							132	-3.5														3 interactions	N452-E456; PAE: 1.0	4 interactions	N452-E456; PAE: 1.0										1.004		0.940		0.890	1 mutation(s) (Asn452Asp: 1.131)	0.857		0.913
453	W	Tryptophan	Aromatic	Helix	H (helix)	H (α-helix)	22	-66.9	-41.7	97.31			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							204	-0.9														2 interactions	W453-K457; PAE: 1.0	3 interactions	W453-K457; PAE: 1.0									1 mutation(s) (Trp453Arg: 0.005)	0.112	1 mutation(s) (Trp453Lys: -0.000)	0.073	4 mutation(s) (Trp453Pro: -0.021, Trp453His: -0.008, Trp453Val: -0.007, Trp453Lys: -0.005)	0.035	1 mutation(s) (Trp453Pro: -0.004)	0.041	6 mutation(s) (Trp453Pro: -0.049, Trp453Lys: -0.008, Trp453Glu: -0.007, Trp453Ile: -0.005, Trp453Cys: -0.002, Trp453Gln: -0.002)	0.041
454	I	Isoleucine	Aliphatic	Helix	H (helix)	H (α-helix)	0	-61.2	-51.6	97.44			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							131	4.5														4 interactions	I454-Y450, I454-T458; PAE: 1.0, 1.0	4 interactions	I454-Y450, I454-T458; PAE: 1.0, 1.0										0.282	1 mutation(s) (Ile454Gly: -0.016)	0.208	2 mutation(s) (Ile454Tyr: -0.012, Ile454Gly: -0.003)	0.184	1 mutation(s) (Ile454Gly: -0.004)	0.177		0.193
455	K	Lysine	Positively-charged	Helix	H (helix)	H (α-helix)	51	-58.0	-48.5	94.82			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107	3 interactions	K455-K459, K455-T461, K455-V451; PAE: 2.5, 4.5, 1.0	4 interactions	K455-K459, K455-L460, K455-V451; PAE: 2.5, 2.0, 1.0										0.929		0.796		0.730	1 mutation(s) (Lys455Lys: 1.107)	0.699		0.760
456	E	Glutamic Acid	Negatively-charged	Helix	H (helix)	H (α-helix)	129	-58.7	-46.2	95.08			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							146	-3.5														3 interactions	E456-N452; PAE: 1.0	3 interactions	E456-N452; PAE: 1.0										0.892		0.904		0.894		0.879		0.956
457	K	Lysine	Positively-charged	Helix	H (helix)	H (α-helix)	79	-76.7	-33.5	95.32			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9														2 interactions	K457-W453; PAE: 1.0	3 interactions	K457-W453; PAE: 1.0										0.969		0.915		0.915	2 mutation(s) (Lys457His: 1.101, Lys457Asn: 1.103)	0.886		0.909
458	T	Threonine	Polar/Neutral		H (helix)	H (α-helix)	5	-90.9	-7.2	93.61			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							119	-0.7														4 interactions	T458-I454; PAE: 1.0	6 interactions	T458-I454; PAE: 1.0										0.424		0.347	1 mutation(s) (Thr458Asp: -0.003)	0.325		0.305		0.341
459	K	Lysine	Positively-charged		C (loop/coil)	T (turn)	187	59.6	25.9	88.35			Coagulation factor IX; Coagulation factor IXa heavy chain						Peptidase S1																							147	-3.9															K459-K455; PAE: 2.5	3 interactions	K459-K455; PAE: 2.5										1.045		1.012		0.970	1 mutation(s) (Lys459Asn: 1.133)	0.946		0.983
460	L	Leucine	Aliphatic		C (loop/coil)	C (loop/coil)	31	-69.7	127.1	78.5			Coagulation factor IX; Coagulation factor IXa heavy chain																													131	3.8												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107				L460-K455; PAE: 2.0										1.051		0.952	1 mutation(s) (Leu460Met: 1.132)	0.945		0.930		0.979
461	T	Threonine	Polar/Neutral		C (loop/coil)	C (loop/coil)	150	-79.8	360.0	62.6			Coagulation factor IX; Coagulation factor IXa heavy chain																													119	-0.7												Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21	0.2107		T461-K455; PAE: 4.5		T461-E159; PAE: 9.5										1.025	1 mutation(s) (Thr461His: 1.172)	1.010		0.996	1 mutation(s) (Thr461His: 1.103)	0.975		1.010